Compounds having excited state intramolecular proton transfer (ESIPT) properties for use in treating and / or preventing sunburn and / or preventing UV damage
Patent Information
- Application Number
- CN202080028486.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2019-03-12
- Filing Date
- 2020-03-12
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2040-03-12
Smart Images

Figure CN113692403B_ABST
Abstract
Description
Technical Field
[0001] The present disclosure relates to the manufacture of molecules having excited state intramolecular proton transfer (ESIPT) properties. Specifically, the present disclosure relates to the use of cashew nut shell liquid (CNSL) phenolics in the manufacture of molecules having ESIPT properties, wherein the molecules are UVA and / or UVB absorbers, and further wherein the molecules are formulated as protectants against UVA and / or UVB radiation. The present disclosure extends to the use of CNSL in the manufacture of compositions comprising molecules having ESIPT properties for the treatment and / or prevention of sunburn and / or prevention of UV damage. Background Art
[0002] Recently, the use of petroleum or petroleum-based products as starting reagents has been moved away from the organic synthesis of commercially relevant chemical products. In order to adopt sustainable carbon sources as starting reagents for organic synthesis, researchers have considered using biomass, especially non-food biomass, which would otherwise be discarded. Therefore, the value addition of non-food biomass has been a topic of much research.
[0003] One non-edible biomass source that has been the subject of much research is cashew nut shell liquid (CNSL). CNSL itself is known to have little commercial value, however, CNSL is rich in phenolics and is known as a non-edible biomass-derived chemical feedstock for the production of paints, resins, polymers, and surfactants. Likewise, there has been a shift in consumer willingness to purchase products derived from non-sustainable sources, where consumers have become reluctant to purchase non-sustainably derived products.
[0004] In particular, in the healthcare and / or skin care fields, as well as in the material protection field, there is a significant push to provide compositions and / or formulations that are not only derived from sustainable sources but are also concomitantly non-toxic to humans or animals, e.g., non-toxic; biodegradable; hypoallergenic; unable to penetrate the skin into tissues or the bloodstream; unable to disrupt hormones; and have virtually no adverse reactions and / or side effects.
[0005] Conventional UV absorbers, including sunscreens, can generally be divided into two categories: (1) physical barriers (such as zinc oxide and titanium dioxide) and (2) chemical absorbers (such as oxybenzone, avobenzone, and otisalate).
[0006] Physical barriers are intended to block ultraviolet (UV) radiation. Chemical absorbers absorb UV radiation. From a quantum mechanical point of view, it is shown that the resonant energy of electron delocalization in aromatic compounds is of the same order of magnitude as the energy of radiation quanta present in the UVA and / or UVB regions of the spectrum. Therefore, UVA and / or UVB radiation can easily cause photochemical excitation of chemical absorber sunscreens.
[0007] By absorbing UV radiation, the absorber molecules are excited from their ground state (S0) to a higher energy state (S1 or T1). When the sunscreen molecules return to the ground state, light of a longer wavelength is emitted, which has a lower energy relative to the UV radiation. Alternatively, a non-radiative process can occur, which only releases heat instead of visible light.
[0008] In general, the absorption of short wavelength light can cause molecules to undergo photochemical reactions, such as cis-trans and / or EZ photochemical isomerization. After cis-trans and / or EZ photochemical isomerization, stereoselective metabolism can have a negative impact on pharmacokinetics, pharmacodynamics and toxicity, and should be avoided. Likewise, unwanted side reactions can occur. The mechanisms associated with radiation can be harmful, not only causing skin irritation but also producing unwanted side reactions, and chemical compounds can be decomposed into toxic components. There is a need for chemical UV absorbers developed from sustainable raw materials that at least improve some of the shortcomings described herein or known in the prior art. Summary of the invention
[0009] According to a first aspect of the present disclosure, there is provided a compound having an excited state intramolecular proton transfer (ESIPT) property, the compound being at least one selected from the following group:
[0010] (i).
[0011]
[0012] (e.g., compound 4c in the specification);
[0013] (ii).
[0014]
[0015] (e.g., compound 10 in the specification);
[0016] (iii).
[0017]
[0018] (e.g., compound 13b in the specification);
[0019] (iv).
[0020]
[0021] (e.g., compound 14 in the specification);
[0022] (v).
[0023]
[0024] (e.g., compound 20 in the specification);
[0025] (vi).
[0026] (Compound 21 in the specification); and
[0027] (vii).
[0028]
[0029] (e.g., compound 23 in the specification);
[0030] wherein for compounds (i) to (vii), R and / or R1 and / or R2 may each be at least one substituent or moiety located at one or more of the ortho, meta and / or para positions on the benzene ring, and may be selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, cycloalkynyl, aryl, heteroaryl, heteroalicyclic, aralkyl, heteroaralkyl, (heteroalicyclic)alkyl, hydroxy, protected hydroxy, alkoxy, aryloxy, acyl, thiol, thioalkyl, arylthio, cyano, halogen, thiocarbonyl, O-carbamyl, The invention also includes but is not limited to alkyl, N-amino, N-carbamoyl, O-thiocarbamoyl, N-thiocarbamoyl, C-amide, N-amide, S-sulfonamide, N-sulfonamide, C-carboxyl, protected C-carboxyl, O-carboxyl, isocyanato, thiocyanato, isothiocyanato, nitro, nitrile, silyl, thiooxy, sulfinyl, sulfonyl, haloalkyl, polyhaloalkyl, haloalkoxy, trihalomethanesulfonyl, trihalomethanesulfonamido, amino, monosubstituted amino and disubstituted amino, ester, alcohol, acetate and protected derivatives of any of the above.
[0031] Compounds (i) to (vii) may be optionally substituted. One or more substituent R groups may be located in the aromatic ring, typically in the ortho, meta and / or para positions on the phenyl ring. The ring may include more than one substituent R group, which may be identical or may be different in chemical structure. Compounds (i) to (vii) may be optionally substituted with multiple R groups, wherein the same R groups or different R groups are connected or bonded to form a chain or ring. A ring may be formed, such as tetrahydronaphthyl.
[0032] According to a second aspect of the present disclosure, there is provided any one or more of compounds (i)-(vii) for use in treating and / or preventing sunburn on a human or animal body, wherein compounds (i)-(vii) are:
[0033] (i).
[0034]
[0035] (e.g., compounds 4, 5 and 6 of the specification);
[0036] (ii).
[0037]
[0038] (For example, compound 10 in the specification);
[0039] (iii).
[0040]
[0041] (e.g., compound 13b of the specification);
[0042] (iv).
[0043]
[0044] (e.g., compound 14 of the specification);
[0045] (v).
[0046]
[0047] (e.g., compound 20 of the specification);
[0048] (vi).
[0049] (e.g., compound 21 of the specification); and
[0050] (vii).
[0051]
[0052] (e.g., compound 23 of the specification);
[0053] wherein for compounds (i) to (vii), R and / or R1 and / or R2 may each be at least one substituent or moiety located at one or more of the ortho, meta and / or para positions on the benzene ring, and may be selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, cycloalkynyl, aryl, heteroaryl, heteroalicyclic, aralkyl, heteroaralkyl, (heteroalicyclic)alkyl, hydroxy, protected hydroxy, alkoxy, aryloxy, acyl, thiol, thioalkyl, arylthio, cyano, halogen, thiocarbonyl, O-carbamyl, The invention also includes but is not limited to alkyl, N-amino, N-carbamoyl, O-thiocarbamoyl, N-thiocarbamoyl, C-amide, N-amide, S-sulfonamide, N-sulfonamide, C-carboxyl, protected C-carboxyl, O-carboxyl, isocyanato, thiocyanato, isothiocyanato, nitro, nitrile, silyl, thiooxy, sulfinyl, sulfonyl, haloalkyl, polyhaloalkyl, haloalkoxy, trihalomethanesulfonyl, trihalomethanesulfonamido, amino, monosubstituted amino and disubstituted amino, ester, alcohol, acetate and protected derivatives of any of the above.
[0054] Compounds (i) to (vii) may be optionally substituted. One or more substituent R groups may be located in the aromatic ring, typically in the ortho, meta and / or para positions on the phenyl ring. The ring may include more than one substituent R group, which may be identical or may be different in chemical structure. Compounds (i) to (vii) may be optionally substituted with multiple R groups, wherein the same R groups or different R groups are connected or bonded to form a chain or ring. A ring may be formed, such as tetrahydronaphthyl.
[0055] The compound can be formulated into a composition for use in treating and / or preventing sunburn on the human or animal body, wherein the composition may include, but is not limited to, at least one of the following groups: water, glycerin, trisodium ethylenediaminetetraacetic acid (EDTA), tocopheryl acetate, phenoxyethanol, cetyl alcohol, xanthan gum, polyethylene glycol (PEG), sodium cetearyl sulfate, glyceryl stearate, and fragrance.
[0056] The applicant has surprisingly found that compounds (i) to (vii) are UVA and UVB absorbers that do not show radiation-related deactivation. The compounds do not undergo any cis-trans and / or EZ isomerization, nor do they decompose into harmful substituents. Surprisingly, the applicant has found that compounds (i) to (vii) dissipate UV radiation by means of an efficient radiation-free deactivation process by means of rapid tautomerization via an excited state intramolecular proton transfer (ESIPT) mechanism. Compounds (i) to (vii) for use in the treatment and / or prevention of sunburn surprisingly improve at least some of the disadvantages known in the prior art.
[0057] According to a third aspect of the present disclosure, there is provided a use of any one or more of the compounds according to the second aspect of the present disclosure in the manufacture of a medicament for treating and / or preventing sunburn of the human or animal body.
[0058] According to a fourth aspect of the present disclosure, there is provided a compound having excited state intramolecular proton transfer (ESIPT) properties, which is produced from cashew nut shell liquid (CNSL) for use in treating and / or preventing sunburn of a human or animal body.
[0059] The compound may be any one or more of the compounds according to the second aspect of the present disclosure.
[0060] The compound can be formulated into a composition for use in treating and / or preventing sunburn on the human or animal body, wherein the composition may include, but is not limited to, at least one of the following groups: water, glycerin, trisodium ethylenediaminetetraacetic acid (EDTA), tocopheryl acetate, phenoxyethanol, cetyl alcohol, xanthan gum, polyethylene glycol (PEG), sodium cetearyl sulfate, glyceryl stearate, and fragrance.
[0061] According to a fifth aspect of the present disclosure, there is provided a use of cashew nut shell liquid (CNSL) for the manufacture of a compound having excited state intramolecular proton transfer (ESIPT) properties, wherein the compound is used for treating and / or preventing sunburn of a human or animal body.
[0062] The compound may be any one or more of the compounds according to the second aspect of the present disclosure.
[0063] The compound can be formulated into a composition for use in treating and / or preventing sunburn on the human or animal body, wherein the composition may include, but is not limited to, at least one of the following groups: water, glycerin, trisodium ethylenediaminetetraacetic acid (EDTA), tocopheryl acetate, phenoxyethanol, cetyl alcohol, xanthan gum, polyethylene glycol (PEG), sodium cetearyl sulfate, glyceryl stearate, and fragrance.
[0064] According to a sixth aspect of the present disclosure, there is provided a method for producing a compound having excited state intramolecular proton transfer (ESIPT) properties, the method comprising the following steps:
[0065] (a) separating phenolic compounds from cashew nut shell liquid (CNSL), preferably the phenolic compounds include but are not limited to at least one of the following groups: anacardic acid, cardanol and cardanol;
[0066] (b). converting the separated phenolic compound into any one or more of the compounds according to the second aspect of the present disclosure.
[0067] The method may include one or more steps as described and / or exemplified below.
[0068] According to a seventh aspect of the present disclosure, provided is a compound having excited state intramolecular proton transfer (ESIPT) characteristics manufactured by the method according to the sixth aspect of the present disclosure.
[0069] The compound may be any one or more of the compounds according to the first aspect of the present disclosure.
[0070] The compound can be formulated into a composition for use in treating and / or preventing sunburn on the human or animal body, wherein the composition may include, but is not limited to, at least one of the following groups: water, glycerin, trisodium ethylenediaminetetraacetic acid (EDTA), tocopheryl acetate, phenoxyethanol, cetyl alcohol, xanthan gum, polyethylene glycol (PEG), sodium cetearyl sulfate, glyceryl stearate, and fragrance.
[0071] According to an eighth aspect of the present disclosure, a method for treating and / or preventing sunburn is provided, comprising applying the compound having excited state intramolecular proton transfer (ESIPT) property produced from cashew nut shell liquid (CNSL) according to the second aspect of the present disclosure to a human or animal body.
[0072] The compound may be any one or more of the compounds according to the second aspect of the present disclosure.
[0073] The compound can be formulated into a composition for use in treating and / or preventing sunburn on the human or animal body, wherein the composition may include, but is not limited to, at least one of the following groups: water, glycerin, trisodium ethylenediaminetetraacetic acid (EDTA), tocopheryl acetate, phenoxyethanol, cetyl alcohol, xanthan gum, polyethylene glycol (PEG), sodium cetearyl sulfate, glyceryl stearate, and fragrance.
[0074] According to a ninth aspect of the present disclosure, there is provided an ultraviolet absorber and protectant composition comprising a compound having excited state intramolecular proton transfer (ESIPT) properties produced from cashew nut shell liquid (CNSL).
[0075] The compound may be according to the first or second aspect of the disclosure.
[0076] The ultraviolet absorber composition may include any one or more of the compounds according to the second aspect of the present disclosure.
[0077] The UV absorber and protectant composition can be formulated as a sunscreen and can include, but is not limited to, at least one of the following group: water, glycerin, trisodium ethylenediaminetetraacetic acid (EDTA), tocopheryl acetate, phenoxyethanol, cetyl alcohol, xanthan gum, polyethylene glycol (PEG), sodium cetearyl sulfate, glyceryl stearate, and fragrance.
[0078] The UV absorber and protectant composition can be formulated as a coating on a material and / or mixed into a material such as a paint, varnish or resin. The coating can include, but is not limited to, a paint, varnish or resin.
[0079] There is further provided any one of the first to eighth aspects of the present disclosure, substantially as described, illustrated and / or illustrated herein with reference to any one of the examples and / or drawings herein. BRIEF DESCRIPTION OF THE DRAWINGS
[0080] Figure 1 Reagents and conditions are shown: (a) n-Buli, THF, -78°C to rt, 2-24h, 3a-c 10-47%; (b) Pd / C, H2, MeOH, EtOAc, rt, 24h, 4a-c, 84-99%; (c) for 4a: AlCl3, pyridine, PhMe, reflux, 4d, 58%; for 4b: BCl3, CH2Cl2, -78°C to rt, 4d, 69%.
[0081] Figure 2 Reagents and conditions are shown: a) PhCOCl, DMAP, Et3N, 2-Me-THF, 0°C to room temperature, 2h, 95%; b) AlCl3, PhCl, Mw (160°C, 150W, 30min), 78%; c) [Ru(p-isopropyltoluene)Cl2]2 (2.5mol%), K2S2O8, TFA / TFAA, 80°C, 14h, 72%.
[0082] Figure 3 Reagents and conditions are shown: (a) CH3COCl, DMAP, Et3N, 2-Me-THF, 0°C to rt, 2h, 93%; (b) AlCl3, PhCl, Mw (160°C, 150W, 30min), quantitative, (c) (i) NaOH, PhCHO, MeOH, 3h, 67% (ii) 0.5N NaOH aqueous solution, H2O2, rt, 4h, 88%.
[0083] Figure 4 Reagents and conditions are shown: (a) 2-fluorobenzoyl chloride, DMAP, Et3N, 2-Me-THF, 0°C to room temperature, 2h, quantitative; (b) AlCl3, PhCl, Mw (160°C, 150W), 30min, 84%; (c) K2CO3, Me2CO, reflux, 6h, 86%; (d) [Ru(p-isopropyltoluene)Cl2]2 (2.5mol%), K2S2O8, TFA / TFAA, 80°C, 12h, 71%; (e) [Ru(p-isopropyltoluene)Cl2]2 (2.5mol%), K2S2O8, TFA / TFAA, 80°C, 12h, 64%.
[0084] Figure 5 Reagents and conditions are shown: (a) SnCl4, Bu3N, (CH2O) n , PhMe, 100℃, 18h, 77%; (b) LiAlH4, THF, room temperature, 6h, 81%; benzamidine hydrochloride, Cu(OAc)2, Na2CO3, PhMe, 110℃, 12h, 62%.
[0085] Figure 6 Reagents and conditions are shown: (a) NH2OH·HCl, FeCl3, DMF, reflux, 18h, 80%; (b) Mw: 220°C, 200W, 1.5h, neat, 73%.
[0086] Figure 7 Reagents and conditions are shown: (a) Et2O, MeOH, rt, 18h, 82%; (b) PhI(OAc)2, Me2CO, rt, 5h, 47%.
[0087] Figure 8 Shown are the UV absorption curves of benzophenones 4c, 5 and 6 derived from anacardic acid.
[0088] Fig. 9 Shown are the UV absorption curves of benzophenones 4c, 5, and 6 derived from cardanol.
[0089] Fig.10 UV curves of chalcone 13a, flavonoid 13b, and xanthone 14 are shown.
[0090] Fig.11 The UV curves of triazines 20 and 21 are shown.
[0091] Fig.12 The UV curve of oxadiazole 23 is shown. DETAILED DESCRIPTION
[0092] The general provisions of the summary of the invention are repeated herein by reference, and are not necessarily repeated in full to avoid repetition. The detailed description and examples hereinafter will include specific embodiments of the present disclosure, and should not be considered to be limiting in any way. Those skilled in the art may envision several alternatives that do not depart from the scope of the present disclosure.
[0093] As discussed above, cashew nut shell liquid (CNSL) has been identified as a sustainably produced biomass and chemical feedstock.
[0094] The major phenolic components of CNSL include, but are not limited to, anacardic acid, cardanol, and cardanol. These phenolic substances are extracted and separated by known organic separation methods for further downstream functionalization and / or transformation and / or synthesis procedures to produce the ultraviolet (UV) radiation absorbing compounds described herein. Specifically, the separated phenolic substances are utilized to produce compounds having excited state intramolecular proton transfer (ESIPT) properties. The compounds having ESIPT properties are used for preventing and / or treating sunburn.
[0095] The compounds having ESIPT properties may also be formulated into compositions such as coatings, paints, resins, polymers and / or varnishes, and / or for use in industrial applications to treat and / or protect materials and / or structures from exposure to UV radiation. This further extension of the disclosure will improve the damaging effects of UV rays that cause discoloration of dyes and pigments; weathering; yellowing of plastics; loss of gloss and mechanical cracking of materials such as plastic materials.
[0096] An ideal organic UV filter shows high UV absorption in the region within the range of 315-400 nm (UVA) and 280-315 nm (UVB).
[0097] Typically, compounds exhibit ESIPT properties when they include intramolecular hydrogen bonding (H-bonding) between proton donor (-OH and -NH2) and proton acceptor (=N- and -C=O) groups in close proximity to each other in the molecule.
[0098] Without being bound by theory, it is hypothesized that the compounds exhibiting ESIPT properties dissipate UV radiation through an efficient radiation-free inactivation process by means of rapid tautomerization via an excited state intramolecular proton transfer (ESIPT) mechanism. This is in contrast to conventional chemical UV absorbers, where radiation-related decomposition can lead to unwanted side effects and unwanted decomposition byproducts, which can be hazardous to human and animal health.
[0099] Besides their petrochemical origin, another major drawback of current chemical UV absorbers is their negative impact on aquatic ecosystems due to their poor biodegradability. As a result, regulatory agency attention is steadily increasing and stricter regulations are being enforced. To this end, new, highly efficient, less toxic and environmentally friendly UV filters need to be developed, ideally in a sustainable manner. More importantly, broad-spectrum UV filters that absorb both UVA and UVB are needed. Recently, concerns have been raised about the carcinogenic effects of titanium dioxide, and more research is needed into healthier means of UV protection.
[0100] Many chemical absorbers absorb UV radiation in only one of the regions UVA, UVB or UVC. This requires that several compounds be formulated into mixtures or compositions to ensure that commercial sunscreens provide adequate protection against UVA, UVB and / or UVC radiation.
[0101] According to a first aspect of the present disclosure, a compound having excited state intramolecular proton transfer (ESIPT) characteristics is provided, wherein the compound is at least one of the above compounds (i) to (vii).
[0102] A second aspect of the present disclosure extends to one or more of compounds (i) to (vii) for use in treating and / or preventing sunburn on the human or animal body.
[0103] Compounds (i) to (vii) may be optionally substituted. One or more substituent R groups may be located in the aromatic ring, typically in the ortho, meta and / or para positions on the phenyl ring. The ring may include more than one substituent R group, which may be identical or may be different in chemical structure. Compounds (i) to (vii) may be optionally substituted with multiple R groups, wherein the same R groups or different R groups are connected or bonded to form a chain or ring. A ring may be formed, such as, but not limited to, tetrahydronaphthyl.
[0104] For compounds (i) to (vii), the groups R and / or R1 and / or R2 may each be at least one substituent or moiety located at the ortho, meta and / or para positions on the benzene ring and may be selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, cycloalkynyl, aryl, heteroaryl, heteroalicyclic, aralkyl, heteroaralkyl, (heteroalicyclic)alkyl, hydroxy, protected hydroxy, alkoxy, aryloxy, acyl, thiol, thioalkyl, arylthio, cyano, halogen, thiocarbonyl, O-carbamoyl, N- -carbamoyl, O-thiocarbamoyl, N-thiocarbamoyl, C-amide, N-amide, S-sulfonamide, N-sulfonamide, C-carboxyl, protected C-carboxyl, O-carboxyl, isocyanato, thiocyanato, isothiocyanato, nitro, nitrile, silyl, thiocyano, sulfinyl, sulfonyl, haloalkyl, polyhaloalkyl, haloalkoxy, trihalomethanesulfonyl, trihalomethanesulfonamido, amino, monosubstituted amino and disubstituted amino, esters, alcohols, acetates and protected derivatives of any of the foregoing.
[0105] The compound can be formulated into a composition for use in treating and / or preventing sunburn on the human or animal body, wherein the composition may include, but is not limited to, at least one of the following groups: water, glycerin, trisodium ethylenediaminetetraacetic acid (EDTA), tocopheryl acetate, phenoxyethanol, cetyl alcohol, xanthan gum, polyethylene glycol (PEG), sodium cetearyl sulfate, glyceryl stearate, and fragrance.
[0106] The third aspect of the disclosure extends to the use of any one or more of compounds (i) to (vii) according to the second aspect of the disclosure in the manufacture of a medicament for treating and / or preventing sunburn of the human or animal body.
[0107] The fourth aspect of the present disclosure extends to compounds having excited state intramolecular proton transfer (ESIPT) properties produced from cashew nut shell liquid (CNSL) according to the second aspect of the present disclosure, which are used to treat and / or prevent sunburn in humans or animals. The compound includes any one or more of compounds (i) to (vii) according to the second aspect.
[0108] The fifth aspect of the present disclosure extends to the use of cashew nut shell liquid (CNSL) for the manufacture of any one of compounds (i) to (vii) having excited state intramolecular proton transfer (ESIPT) properties, wherein the compound is used to treat and / or prevent sunburn on the human or animal body, wherein the compound is according to the second aspect.
[0109] A sixth aspect of the present disclosure extends to a method of making a compound having excited state intramolecular proton transfer (ESIPT) properties, the method comprising the steps of:
[0110] (a) separating phenolic compounds from cashew nut shell liquid (CNSL), preferably the phenolic compounds include but are not limited to at least one of the following groups: anacardic acid, cardanol and cardanol;
[0111] (b). converting the separated phenolic compound into any one or more of the compounds according to the second aspect of the present disclosure.
[0112] The method may include one or more steps as described and / or illustrated below.
[0113] A seventh aspect of the present disclosure extends to compounds having excited state intramolecular proton transfer (ESIPT) properties made according to the methods described and / or illustrated and / or exemplified herein.
[0114] An eighth aspect of the present disclosure provides a method for treating and / or preventing sunburn, comprising applying a compound having an excited state intramolecular proton transfer (ESIPT) property produced by cashew nut shell liquid (CNSL) to a human or animal body. Typically, the compound comprises any one or more of compounds (i) to (vii) according to the second aspect, and the compound is typically formulated into a composition for easy application to the skin of a human or animal body. The composition typically comprises an aerosol or a cream / lotion.
[0115] Finally, the ninth aspect of the present disclosure extends to a UV absorber and protectant composition comprising a compound having excited state intramolecular proton transfer (ESIPT) properties produced from cashew nut shell liquid (CNSL). The UV absorber composition comprises at least one of compounds (i) to (vii) according to the first or second aspect.
[0116] The UV absorber and protectant composition is formulated as a sunscreen and may include, but is not limited to, at least one of the following group: water, glycerin, trisodium ethylenediaminetetraacetic acid (EDTA), tocopheryl acetate, phenoxyethanol, cetyl alcohol, xanthan gum, polyethylene glycol (PEG), sodium cetearyl sulfate, glyceryl stearate, and fragrance.
[0117] The UV absorber and protectant composition can be formulated as a coating of a material and / or mixed into a material such as a paint, varnish or resin. The coating may include, but is not limited to, a paint, varnish or resin. When formulated as a coating of a material, the UV absorber composition used protects the coating material from UV radiation. This is an important application in buildings, outdoor furniture, roofs, window frames, etc.
[0118] The applicant has surprisingly found that compounds (i) to (vii) are UVA and UVB absorbers that do not show radiation-related deactivation. The compounds do not undergo any cis-trans and / or EZ isomerization, nor do they decompose into harmful substituents. Surprisingly, the applicant has found that compounds (i) to (vii) dissipate UV radiation by means of an efficient radiation-free deactivation process by means of rapid tautomerization via an excited state intramolecular proton transfer (ESIPT) mechanism. Compounds (i) to (vii) for use in the treatment and / or prevention of sunburn surprisingly improve at least some of the disadvantages known in the prior art.
[0119] It is also important to provide a water resistant sunscreen. In compounds (i) to (vii) according to the first and second aspects, the long alkyl chain together with the functionalization providing the ESIPT property surprisingly provides water resistance by ensuring absorption into the skin. Known chemical sunscreens such as oxybenzone are known to wash off the skin easily and are known to be highly toxic to corals. This surprising discovery has led to some jurisdictions completely banning sunscreens containing oxybenzone. The alkyl chain may be from about 1 to about 20 carbons.
[0120] Applicants believe that the disclosed subject matter described herein improves at least one of the shortcomings currently known in the prior art.
[0121] Whenever a compound described herein, typically compounds (i) to (vii) of one or both aspects of the first and second aspects of the invention, is described as "optionally substituted", the compound may be unsubstituted or substituted by one or more of the specified substituent R groups. Similarly, when a compound is described as "unsubstituted or substituted", if substituted, the substituent (one or more) may be selected from one or more specified substituents. If no substituent is specified, it means that the specified "optionally substituted" or "substituted" group may be substituted by one or more groups selected individually and independently from the following: hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, cycloalkynyl, aryl, heteroaryl, heteroalicyclic, aralkyl, heteroaralkyl, (heteroalicyclic) alkyl, hydroxyl, protected hydroxyl, alkoxy, aryloxy, acyl, sulfhydryl, thioalkyl, arylthio, cyano, halogen, thiocarbonyl, O-carbamoyl, N-carbamoyl, O-thiocarbamoyl, N-thiocarbamoyl, C-amide, N-amide, S-sulfonamide, N-sulfonamide, C-carboxyl, protected C-carboxyl, O-carboxyl, isocyanato, thiocyanato, isothiocyanato, nitro, nitrile, silyl, thiocyano, sulfinyl, sulfonyl, haloalkyl, polyhaloalkyl, haloalkoxy, trihalomethanesulfonyl, trihalomethanesulfonamido, amino, monosubstituted amino and disubstituted amino, esters, alcohols, acetates and protected derivatives of any of the foregoing.
[0122] As used herein, the term "alkyl" is a broad term and has the ordinary and customary meaning to those of ordinary skill in the art (and is not limited to a special or customary meaning), and is not limited to straight or branched chain, acyclic or cyclic, unsaturated or saturated aliphatic hydrocarbons containing 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36 or more carbon atoms. Representative saturated straight chain alkyls include methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, and the like; while saturated branched chain alkyls include isopropyl, sec-butyl, isobutyl, tert-butyl, isopentyl, and the like. Unsaturated alkyl groups contain at least one double bond or triple bond between adjacent carbon atoms (referred to as "alkenyl" or "alkynyl", respectively). Representative straight-chain and branched alkenyl groups include ethenyl, propenyl, 1-butenyl, 2-butenyl, isobutenyl, 1-pentenyl, 2-pentenyl, 3-methyl-1-butenyl, 2-methyl-2-butenyl, 2,3-dimethyl-2-butenyl, and the like; while representative straight-chain and branched alkynyl groups include ethynyl, propynyl, 1-butynyl, 2-butynyl, 1-pentynyl, 2-pentynyl, 3-methyl-1-butynyl, and the like. Typical alkyl groups include, but are by no means limited to, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl, eicosyl, heneicosyl, docosyl, tricosyl, tetracosyl, pentacosyl, hexacosyl, heptacosyl, octacosyl, nonacosyl, triacontyl, trineicosyl, dotriacontyl, tritriacontyl, tetratriacontyl, pentatriacontyl and hexatriacontyl. The alkyl group may be substituted or unsubstituted.
[0123] The term "alkoxy" as used herein is a broad term and has its ordinary and customary meaning to those of ordinary skill in the art (and is not limited to a special or customary meaning), and is not limited to alkyl moieties attached through an oxygen bridge (i.e., -O-alkyl), such as methoxy, ethoxy, and the like.
[0124] The term "thioalkyl" as used herein is a broad term and has its ordinary and customary meaning to those of ordinary skill in the art (and is not limited to a special or customary meaning), and is not limited to alkyl moieties attached through a sulfur bridge (i.e., -S-alkyl), such as methylthio, ethylthio, and the like.
[0125] The term "alcohol" as used herein is a broad term and has the ordinary and customary meaning to those of ordinary skill in the art (and is not limited to a special or customary meaning), and is not limited to any compound that incorporates one or more hydroxyl groups, or is substituted with one or more hydroxyl groups or functionalized to include one or more hydroxyl groups as described herein.
[0126] The term "ester" as used herein is a broad term and has the ordinary and customary meaning to one of ordinary skill in the art (and is not limited to a special or customary meaning), and is not limited to any compound that incorporates one or more ester groups, such as a monoester, diester, triester, or polyester, or is substituted with one or more ester groups or functionalized to include one or more ester groups as described herein. Esters include, but are not limited to, fatty acid esters.
[0127] The term "acetates" as used herein is a broad term and has the ordinary and customary meaning to those of ordinary skill in the art (and is not limited to a special or customary meaning), and is not limited to any compound incorporating one or more acetate groups as described herein, such as a salt, ester, or other compound incorporating a CH3COO- moiety.
[0128] Specific embodiments of the present disclosure
[0129] Different classes of potential UV absorbers were prepared in a short and efficient synthetic sequence using CNSL-derived cardanol and anacardic acid as starting materials. Hydrogen bonding of the phenolic hydroxyl group to the C=X-moiety of the chromophore is a central design feature to ensure efficient ESIPT, which increases photostability and reduces phototoxicity (where X is a halogen). First, benzophenones and xanthones with adjacent OH-groups were synthesized.
[0130] synthesis:
[0131] Synthesis of Benzophenone (Compounds 4c, 5 and 6)
[0132] refer to Figure 1 , starting from CNSL-derived anacardic acid, the benzyl-protected methyl ester 1 was prepared using known procedures. Figure 1 As shown, exposure of substituted bromobenzenes 2(a, b, c) to n-BuLi followed by addition of ester 1 leads to the formation of protected benzophenones 3(a, b, c). O-debenzylation of 3(a, b, c) using Pd / C under a hydrogen atmosphere affords benzophenones 4(a, b, c) in excellent yields. Benzophenone 4c contains two hydrogen-bonded phenols. Exposure of 4a to AlCl3 yields compound 5, while hydrogen-bonded 2,2′-dihydroxybenzophenone 6 is obtained by treating 4b with BCl3. Figure 1 Reagents and conditions are shown: (a) n-Buli, THF, -78°C to rt, 2-24h, 3a-c 10-47%; (b) Pd / C, H2, MeOH, EtOAc, rt, 24h, 4a-c, 84-99%; (c) for 4a: AlCl3, pyridine, PhMe, reflux, 4d, 58%; for 4b: BCl3, CH2Cl2, -78°C to rt, 4d, 69%.
[0133] An additional benzophenone with two hydrogen-bonded phenols was synthesized using CNSL-derived cardanol 7 as the starting material. Esterification of cardanol 7 with benzoyl chloride afforded ester 8 in excellent yield. Microwave-promoted Fries rearrangement of 8 was subsequently performed in the presence of AlCl3 to afford benzophenone 9. Palladium-mediated CH oxidation of 9 afforded 2,2′-dihydroxybenzophenone 11 in 61% yield ( Figure 2 ). Figure 2 Reagents and conditions are shown: a) PhCOCl, DMAP, Et3N, 2-Me-THF, 0°C to room temperature, 2h, 95%; b) AlCl3, PhCl, Mw (160°C, 150W, 30min), 78%; c) [Ru(p-isopropyltoluene)Cl2]2 (2.5mol%), K2S2O8, TFA / TFAA, 80°C, 14h, 72%.
[0134] Synthesis of 3-hydroxyflavone (Compound No. 13)
[0135] Another class of potential UV absorbers with a hydroxyl group hydrogen-bonded to a carbonyl substituent is flavonoids. Using CNSL-derived cardanol 7, the first step was to Figure 2 The initial O-acetylation of cardanol 7 was accomplished in a similar manner to afford 11. Similarly, microwave-assisted Fries rearrangement of 11 under AlCl3 catalysis afforded 1-(2-hydroxyphenyl)ethanone 12 in excellent overall yield. Aldol condensation of 12 with benzaldehyde afforded the aldol intermediate 13a. If subsequently oxidized in situ with hydrogen peroxide, the desired 3-hydroxyflavone 13b was obtained in a reasonable yield of 67% in two steps, as shown in FIG. Figure 3 Because acetic acid and benzaldehyde are derived from wood-based chemicals, in other words, lignochemicals, the entire molecular skeleton of 13a and 13b is derived from biomass. Figure 3Reagents and conditions are shown: (a) CH3COCl, DMAP, Et3N, 2-Me-THF, 0°C to room temperature, 2h, 93%; (b) AlCl3, PhCl, Mw (160°C, 150W, 30min), quantitative, (c) (i) NaOH, PhCHO, MeOH, 3h, 67% (ii) 0.5N NaOH aqueous solution, H2O2, room temperature, 4h, 88%. Since acetic acid and benzaldehyde are wood chemicals, the entire molecular skeleton of 13a and 13b is derived from biomass.
[0136] Synthesis of Xanthone Derivative (Compound No. 14)
[0137] The next class of compounds investigated as potential UV absorbers was the hydrogen-bonded xanthones. For example, 1,8-dihydroxyxanthones 14 were synthesized from cardanol from CNSL. Using the methods described previously, the Fries rearrangement of 15 was used to assemble benzophenone 16 in two steps with 84% yield ( Figure 4 ). Reflux of 16 with potassium carbonate in acetone yielded xanthone 17. Ruthenium-catalyzed CH oxidation of 16 provided the desired 1,8-dihydroxyxanthone 14 in two steps in a typical yield of 54%. Since 2-fluorobenzoic acid can be synthesized from anthranilic acid, the entire molecular skeleton of 14 was derived via lignin chemical synthesis. Figure 4 Reagents and conditions are shown: (a) 2-fluorobenzoyl chloride, DMAP, Et3N, 2-Me-THF, 0°C to room temperature, 2h, quantitative; (b) AlCl3, PhCl, Mw (160°C, 150W), 30min, 84%; (c) K2CO3, Me2CO, reflux, 6h, 86%; (d) [Ru(p-isopropyltoluene)Cl2]2 (2.5mol%), K2S2O8, TFA / TFAA, 80°C, 12h, 71%; (e) [Ru(p-isopropyltoluene)Cl2]2 (2.5mol%), K2S2O8, TFA / TFAA, 80°C, 12h, 64%.
[0138] Synthesis of triazines (compound numbers 20 and 21)
[0139] Nitrogen-containing compounds such as 2-hydroxytriazine were investigated. 2-(4,6-diphenyl-1,3,5-triazin-2-yl)phenol 20 was synthesized in three steps from CNSL-derived cardanol. Figure 5As shown, SnCl4-mediated formylation of cardanol 7 afforded benzaldehyde 18 in excellent yield, and subsequent LiAlH4-reduction of aldehyde 18 gave benzyl alcohol 19. Alcohol 19 was exposed to benzamidine in the presence of Cu(OAc)2 to afford 2-(4,6-diphenyl-1,3,5-triazin-2-yl)phenol 20 in 62% yield. The second organic building block, benzamidine, can be prepared from either benzoic acid or benzaldehyde and can therefore be considered compatible with the principles of wood chemistry. Figure 5 Reagents and conditions are shown: (a) SnCl4, Bu3N, (CH2O) n , PhMe, 100℃, 18h, 77%; (b) LiAlH4, THF, room temperature, 6h, 81%; benzamidine hydrochloride, Cu(OAc)2, Na2CO3, PhMe, 110℃, 12h, 62%.
[0140] To evaluate the effect of increasing the number of hydrogen-bonded NH units within the molecule on UV absorption, 2,2′,2″-(1,3,5-triazine-2,4,6-triyl)triphenol 22 was also prepared. This was expected to be readily prepared from formylated cardanol intermediate 18, e.g. Figure 6 Reaction of aldehyde 18 with hydroxylamine hydrochloride and FeCl3 in DMF under reflux conditions gave nitrile 22, which could be trimerized by microwave irradiation to afford s-triazine 21 in 73% yield, thus affording a triazine with three potentially hydrogen-bonded NH substituents. Figure 6 Reagents and conditions are shown: (a) NH2OH·HCl, FeCl3, DMF, reflux, 18h, 80%; (b) Mw: 220°C, 200W, 1.5h, neat, 73%.
[0141] Synthesis of Oxadiazole (Compound No. 23)
[0142] The oxadiazole 23 was synthesized, which should also show NH hydrogen bonding and thus be UV-filtered for oxadiazole 23. Exposure of aldehyde 18 to the hydrazide of veratric acid 24 gave 25. Condensation and oxidative oxadiazole ring formation produced 23 in 39% overall yield in two steps ( Figure 7 ). The reagents and conditions are shown: (a) Et2O, MeOH, room temperature, 18h, 82%; (b) PhI(OAc)2, Me2CO, room temperature, 5h, 47%.
[0143] UV absorption curves of synthesized compounds
[0144] The synthesized compounds 4c, 5, 6, 9, 10, 13a, 13b, 14, 20, 21 and 23 were analyzed for UV absorption and their molar absorption coefficients (ε) were determined. UV absorption analysis was performed to determine whether the compounds exhibited ε values comparable to UV absorbers in the UV-B and UV-A regions of the UV spectrum.
[0145] 2,2′-Dihydroxybenzophenone 4c synthesized from anacardic acid showed reasonable UV absorption in the UVA region, with an experimental ε value of 10,538 L mol at 335 nm. -1 cm -1 and 36,366 L mol at 261 nm -1 cm -1 High absorption, despite being outside the UVA and UVB regions ( Figure 8 ). Benzophenone 5 exhibited an ε value of 8,785 L mol at 374 nm. -1 cm -1 and 18,439 L mol at 265 nm -1 cm -1 Benzophenone 6 showed excellent UVA absorption with an ε value of 25,014 L mol at 358 nm. -1 cm -1 and 34,096 L mol at 287 nm -1 cm -1 .
[0146] Figure 8 The UV absorption curves of benzophenones 4c, 5, and 6 derived from anacardic acid are shown. In contrast, benzophenones 9 and 10 derived from cardanol show excellent absorption at the edge of the UVB region, with experimental ε values of 47,909 L mol at 279 nm for mono- and dihydroxy-benzophenones, respectively. -1 cm -1 and 31,659 L mol at 282 nm -1 cm -1 ,like Fig. 9 shown. Fig. 9 Shown are the UV absorption curves of benzophenones 4c, 5, and 6 derived from cardanol.
[0147] like Figure 3 As shown, 3-hydroxyflavone 13b showed an excellent absorption curve in the UVA region, with an experimental ε value of 39,870 L mol at 314 nm. -1 cm -1 and 44,979 L mol at 345 nm -1 cm -1The intermediate phenylpropenone 13a showed an experimental ε value of 20,403 L mol at 314 nm. -1 cm -1 and 10,250 L mol at 347 nm -1 cm -1 Dihydroxyxanthone 14 exhibited a good UV absorption curve, with an ε value of 23,765 L mol at 254 nm. -1 cm -1 ( Fig.10 ). However, UVC is less relevant at sea level due to the filtering function of the atmospheric ozone layer. Fig.10 UV curves of chalcone 13a, flavonoid 13b, and xanthone 14 are shown.
[0148] s-Triazine 21 showed the best UV absorption in both UVA and UVB regions, with an experimental ε value of 21,452 L mol at 300 nm. -1 cm -1 and 12,515 L mol at 364 nm -1 cm -1 These results indicate that 21 can be classified as a broad-spectrum UV filter, since it shows excellent results in both relevant UV regions. On the other hand, 2-(4,6-diphenyl-1,3,5-triazin-2-yl)phenol 20 exhibits excellent UV absorption at the beginning of the UVB region, with an ε value of 29,252 L mol at 278 nm. -1 cm -1 ( Fig.11 ). Fig.11 The UV curves of triazines 20 and 21 are shown.
[0149] like Fig.12 As shown, oxadiazole 23 shows moderate UV absorption in the UVA region with an experimental ε value of 6,367 L mol at 326 nm. -1 cm -1 and 3,373 L mol at 293 nm -1 cm -1 . Fig.12 The UV curve of oxadiazole 23 is shown.
[0150] Chemical absorbents of the prior art:
[0151] The commercially available sunscreen protectants oxybenzone (OB), 2-ethylhexyl 4-methoxycinnamate (OMC), and avobenzone) are reported to show experimental molar absorption coefficients of 15,150 at 287 nm, 39,470 at 356 nm, and 31,670 at 310 nm, respectively. Some of our compounds are in approximately the same absorption range, and others are even better than the commercial compounds.
[0152] in conclusion
[0153] CNSL is used as a non-edible bio-renewable chemical raw material to synthesize various types of UV filters. In addition, the principles of wood chemistry are used where possible. The UV curves of these compounds are expected to be used as potential applications as sunscreens in paints and other related industries. Cytotoxicity assessments are currently being conducted on these compounds. Without being limited to theory, it is hypothesized that long aliphatic chains improve the lipophilicity of the manufactured compounds, allowing the compound (one or more) to be more easily applied to human or animal skin, and preventing the compound from being washed off by water, thereby providing a good sunscreen product when used. The aliphatic chain can be from about 1 to about 20 carbons, but is typically exemplified herein as 14 carbons.
[0154] More detailed synthesis scheme
[0155] The solvents used for chromatography techniques (ethyl acetate, cyclohexane and n-hexane) were distilled by conventional distillation processes before use. The solvents used in the reaction were first dried with a suitable drying agent and then distilled under an inert atmosphere (argon or nitrogen). Acetonitrile and dichloromethane were distilled with calcium hydride, while tetrahydrofuran was distilled with sodium using benzophenone as an indicator. Toluene was distilled with sodium. All required chemicals or reagents were obtained from TCI, AcrosOrganics, Fluka, Sigma Aldrich or Merck and can be used without additional purification.
[0156] Conventional chromatography was performed on silica gel 60 (Macherey-Nagel, particle size 0.063-0.200 mm) using both isocratic and gradient elution systems. Flash chromatography purification was performed on silica gel (Across Organics, particle size 35-70 μm) using a semi-automatic Biotage Isolera One system with an integrated UV detector and silica gel column or manually packed columns with a nitrogen pressure of 0.4-0.6 bar. Thin layer chromatography (TLC) of the compounds was performed on Macherey-Nagel Alugram Silica G / UV254 plates pre-coated with 0.25 mm silica gel 60 or on Merck TLC Silica 60F 254The TLC plates were observed under UV light (254 nm and 366 nm). Nuclear magnetic resonance (NMR) spectra were recorded on Bruker AVANCE, Bruker AVANCE III HD (all 300 MHz), Bruker AVANCE II (400 MHz), Bruker AVANCE III 500 MHz or Bruker AVANCE III (600 MHz) spectrometers. All chemical shift values (δ) are relative to tetramethylsilane (TMS) reference TMS (δ TMS = 0 ppm) or the signal of residual protonated solvent (CDCl3: δ 1H =7.26ppm, δ 13C =77.16ppm; DMSO-d6: δ 1H =2.50ppm, δ 13C =39.52 ppm) is reported in parts per million. Coupling constants (J values) are given in Hertz (Hz). Infrared spectra were recorded on a Bruker Tensor 27 FT-IR spectrometer with a diamond ATR device. The measurements are in wavenumber scale. Report to the unit.
[0157] Melting points were determined on a Reichert hot stage microscope or a Krüss-Optronic KSP 1N instrument and remain uncorrected. All crystalline compounds were recrystallized from a suitable solvent before determining the melting point. Microwave reactions were performed in a CEM Discover microwave.
[0158] High resolution mass spectra (HRMS) were obtained using a Waters-LCT-Premier mass spectrometer. The sample was dissolved in methanol to a concentration of 2 ng / μl and introduced by direct injection. The ionization mode was positive electrospray (ESI) with a capillary voltage of 2500 V, a desolvation temperature of 250°C, and nitrogen gas at a flow rate of 250 liters / hour. Alternatively, ESI-HRMS was performed using an Agilent 6545QTOF-MS with a suitable external calibrant.
[0159] 2-Benzyloxy-6-pentadecylbenzoic acid methyl ester 1
[0160] A suspension of calcium anacardate (20.0 g, about 52.3 mmol) in aqueous HCl (10%, 100 mL) was stirred at room temperature for 3 h. Then, EtOAc (100 mL) was added and the mixture was stirred for 1 h, and the layers were separated. The aqueous layer was extracted with EtOAc (2×50 mL), and the combined organic extracts were washed with brine (30 mL). After drying with MgSO4 and evaporation of the solvent, anacardic acid (13.7 g, about 39.9 mmol, 76%) was obtained as a brown oil. IR 2923,2853,1644,1607,1447,1245,1207,1166,910,822,783; 1 H NMR (300MHz, chloroform-d) δ11.01(s,1H),9.62(s,2H),7.35(dd,J=8.3,7.5Hz,1H),6.86(dd,J=8.4, 1.2Hz,1H),6.76(dd,J=7.5,1.2Hz,1H),5.81(ddt,J=17.3,10.1,6.2Hz,0.4H),5.51–5.24(m, 4H),5.04(dq,J=17.1,1.8Hz,0.4H),4.97(dq,J=10.1,1.6Hz,0.4H),3.05–2.94(m,2H),2.87– 2.68(m,2H),2.04–1.94(m,3H),1.69–1.53(m,2H),1.44–1.19(m,21H),0.99–0.83(m,3H)ppm; 13 C NMR (76 MHz, chloroform-d) δ 176.0, 163.5, 147.7, 136.8, 135.3, 130.4, 130.1, 129.9, 129.8, 129.3, 128.1, 128.0, 127.6, 126.8, 122.7, 115.8, 114.7, 110.5, 36.4, 32.0, 31.8, 31.5, 29.7, 29.4, 29.23, 29.0, 27.2, 25.6, 22.8, 22.6, 14.1; MS (ESI+): m / z (%) = 343.5 (100) [M 3DB +H] + ,345.5(97)[M 2DB +H] + ,347.4(100)[M 1DB +H] + ,365.5(26)[M 3DB +Na] + ,367.4(35)[M 2DB +Na] +,369.4(39)[M 1DB +Na] + The index “DB” indicates the number of double bonds present. The analytical data are consistent with the literature
[20] .
[0161] Under nitrogen atmosphere, palladium on activated carbon (10 wt%, 600 mg, 0.56 mmol) was added to a solution of anacardic acid (10.2 g, 29.6 mmol) in MeOH (125 mL). The flask was purged with hydrogen, and the suspension was stirred at room temperature under hydrogen atmosphere for 60 h. Then, the flask was purged with nitrogen, and the reaction mixture was stirred by Filtered. After rinsing with MeOH (300 mL), the solvent was evaporated and 2-hydroxy-6-pentadecylbenzoic acid (10.0 g, 28.8 mmol, 97%) was obtained as a light brown solid. Mp. 87-88 °C; IR : 2916, 2850, 1651, 1604, 1445, 1248, 1218, 815, 724, 707; 1 H NMR (300 MHz, chloroform-d) δ7.36 (t, J = 7.9 Hz, 1H, H4), 6.87 (d, J = 8.3 Hz, 1H, H3), 6.77 (dd, J = 7.5, 1.2 Hz, 1H, H5), 2.98 (dd, J = 9.1, 6.4 Hz, 2H, H1′), 1.65–1.55 (m, 2H, H2′), 1.39–1.25 (m, 24H, H3′–H14′), 0.88 (t, J = 6.3 Hz, 3H, H15′) ppm; 13 C NMR (76 MHz, chloroform-d) δ 176.0 (CO2H), 163.6 (C2), 147.8 (C6), 135.4 (C4), 122.7 (C5), 115.8 (C3), 110.4 (C1), 36.5 (C1'), 32.0 (C13'), 31.9 (C2'), 29.8, 29.7 (6C), 29.6, 29.5, 29.4, 22.7 (C14'), 14.1 (C15') ppm; MS (ESI-): m / z (%) = 347.3 (100) [M-H] – ,717.6(12)[2M+Na–2H] – ; HRMS (ESI–): found (M–H) – 347.2592, C 22 H 35 O3(M–H) – Requires 347.2592. The analysis data is consistent with the literature.
[20]
[0162] Concentrated sulfuric acid (2.50 mL, 139 μmol) was carefully added to a stirred solution of 2-hydroxy-6-pentadecylbenzoic acid (2.00 g, 5.74 mmol) in MeOH (50 mL). The resulting mixture was stirred at reflux overnight and then cooled to room temperature. The solvent was evaporated and saturated NaHCO3 aqueous solution (30 mL) was added to the residue. After extraction with EtOAc (3×25 mL), the combined organic extracts were then washed with water and brine (20 mL each) and dried over MgSO4. The solvent was evaporated and the crude product was purified by silica gel column chromatography (20% EtOAc / hexane) to give methyl 2-hydroxy-6-pentadecylbenzoate (1.67 g, 4.71 mmol, 82%) as a light brown solid. Mp.41.5–43°C; IR : 2914, 2850, 1662, 1578, 1441, 1315, 1201, 1120, 946, 817, 742; 1 H NMR (300 MHz, chloroform-d) δ 11.10 (s, 1H, OH), 7.28 (dd, 3 J 4,3 =8.4Hz, 3 J 4,5 =7.5Hz,1H,H4),6.83(dd,J=7.5,1.3Hz,1H,H3),6.71(dd,J=7.5,1.3Hz,1H,H5),3.95(s,3H,CO2CH3),2.88(dd ,J=8.8,6.8Hz,2H,H1'),1.56–1.47(m,2H,H2'),1.36–1.24(m,24H,H3'–H14'),0.88(t,J=7.0Hz,3H,H15')ppm; 13 C NMR (76 MHz, chloroform-d) δ 171.9 (CO2CH3), 162.6 (C2), 146.2 (C6), 134.1 (C4), 122.4 (C5), 115.6 (C3), 111.8 (C1), 52.0 (CO2CH3), 36.6 (C1'), 32.1 (C13'), 31.9 (C2'), 29.9, 29.7-29.6 (7C), 29.5, 29.3, 22.7 (C14'), 14.1 (C15') ppm; MS (ESI-): m / z (%) = 361.4 (100) [M-H] – ; HRMS (ESI+): found (M+H) + 363.2889, C 23 H 39 O3(M+H) +Requires 363.2894. The analysis data is consistent with the literature.
[21]
[0163] A suspension of methyl 2-hydroxy-6-pentadecylbenzoate (1.20 g, 3.31 mmol) and K2CO3 (915 mg, 6.62 mmol) in acetone (20 mL) was stirred at reflux for 10 min. After cooling to room temperature, benzyl bromide (591 μL, 4.97 mmol) was carefully added and the mixture was stirred at reflux for 8 h under a nitrogen atmosphere. The mixture was cooled to room temperature and heated to room temperature by Filter and rinse with acetone (100 mL). After evaporation of the solvent, the crude product was purified by silica gel column chromatography (5% EtOAc / hexane) to obtain methyl 2-benzyloxy-6-pentadecylbenzoate 1 (1.25 g, 2.76 mmol, 83%) as a colorless solid. Mp. 29–31 °C; IR : 2922, 2852, 1732, 1583, 1453, 1264, 1109, 1066, 734; 1 H NMR (300MHz, chloroform-d) δ7.42–7.29 (m, 5H, Bn-H2–Bn-H6), 7.23 (dd, J=8.4, J7.7 Hz,1H,H4),6.83(d,J=7.5Hz,1H,H5),6.78(dd,J=7.7,1.0Hz,1H,H3),5.10(s,2H,Bn-CH2),3.89(s,3H,CO2CH3) ,2.59–2.53(m,2H,H1′),1.63–1.54(m,2H,H2’),1.33–1.23(m,24H,H3’–H14’),0.88(t,J=6.5Hz,3H,H15’)ppm; 13 C NMR (76 MHz, chloroform-d) δ 168.8 (CO2CH3), 155.4 (C2), 141.5 (C6), 136.9 (Bn-C1), 130.1 (C4), 128.4 (2C, Bn-C3, Bn-C5), 127.7 (Bn-C4), 126.8 (2C, Bn-C2, Bn-C6), 124.1 (C1), 121.8 (C5), 1 10.0(C3),70.4(Bn-CH2),52.0(CO2CH3),33.5(C1'),31.9(C13'),31.1(C2'),29.7(6C),2 9.5(2C),29.4,29.3,22.7(C14'),14.1(C15')ppm; MS(ESI+): m / z(%)=21.5(98)[M–OMe+H] + ,453.5(100)[M+H] +,475.4(54)[M+Na] + ; HRMS (ESI+): found (M+H) + 453.3358, C 30 H 45 O3(M+H) + Requires 453.3363.
[0164] General procedure for the synthesis of benzophenones 3a-c
[0165] Corresponding bromobenzene 2a-c (1.05mmol) is added to the 50mL Schlenk flask of flame drying, and the flask is subsequently evacuated and filled with nitrogen three times.Add dry THF (5mL), under stirring, the solution is cooled to -83 ℃.During 15min, add the hexane solution (1.39m, 752 μL, 1.05mmol) of n-butyl lithium.The gained mixture is stirred for 1h at -83 ℃, and during 15min, add the dry THF (5mL) solution of 2-benzyloxy-6-pentadecylbenzoic acid methyl ester 1 (430mg, 0.95mmol).After stirring 1h at -83 ℃, the solution is slowly warmed to room temperature and stirred in addition.Mixture is saturated NH4Cl solution (10mL) is quenched and extracted with EtOAc (3 × 10mL).The organic extract MgSO4 of merging is dried and evaporated.The crude product is purified by silica gel column chromatography (EtOAc / hexane).
[0166] [2-(Benzyloxy)-6-pentadecylphenyl](2,5-dimethoxyphenyl)methanone 3a
[0167] The title compound was synthesized from 2,5-dimethoxybromobenzene 2a (157 μL, 1.05 mmol) and methyl 2-benzyloxy-6-pentadecylbenzoate 1 (430 mg, 0.95 mmol) according to the general procedure. The resulting solution was stirred at room temperature overnight, and the crude product was purified by silica gel column chromatography (5-10% EtOAc / hexane) to produce [2-(benzyloxy)-6-pentadecylphenyl] (2,5-dimethoxyphenyl)methanone 3a (245 mg, 438 μmol, 46%) as a colorless solid. Mp. 53.5–54.5 °C; IR : 2923, 2853, 1656, 1579, 1495, 1464, 1281, 1221, 1048, 745; 1H NMR (300MHz, chloroform-d) δ7.26–7.18(m,5H,H6,H4',Bn-H3,Bn-H4,Bn-H5),7.04–6.97(m,3H,H4,B n-H2,Bn-H6),6.86(d,J=7.9Hz,1H,H5'),6.84(d,J=8.9Hz,1H,H3),6.75(dd,J=8.3,0.9Hz,1 H,H3'),4.91(s,2H,Bn-CH2),3.72(s,3H,C5-OCH3),3.52(s,3H,C2-OCH3),2.57–2.51(m,2H, H1“),1.57–1.50(m,2H,H2“),1.33–1.20(m,24H,H3“-H14“),0.88(t,J=7.0Hz,3H,H15“)ppm; 13 C NMR (76 MHz, chloroform-d) δ 196.5 (C=O), 155.6 (C2'), 153.8 (C2), 153.3 (C5), 141.6 (C6'), 136.8 (Bn-C1), 132.0 (C1'), 129.6 (C1), 129.4 (C4'), 128.1 (2C, Bn-C3, Bn-C5), 127.4 (Bn-C4), 126.8 (2C, Bn-C2, Bn-C6), 122.1 (C5'), 120.0(C4),115.2(C6),114.0(C3),109.3(C3'),56.4(C2-OCH3),55.7(C5-OCH3),33.1(C1″),31.9(C13″),3 1.2(C2″),29.7(6C),29.6(2C),29.4(2C),22.7(C14″),14.1(C15″)ppm; MS(ESI+): m / z(%)=559.5(100)[M+H] + ,581.5(12)[M+Na] + ; HRMS (ESI+): found (M+H) + 559.3776, C 37 H 51 O4(M+H) + Requires 559.3782.
[0168] [2-(Benzyloxy)-6-pentadecylphenyl](2,4,5-trimethoxyphenyl)methanone 3b
[0169] Under a nitrogen atmosphere, NBS (2.12 g, 11.9 mmol) was added to a solution of 1,2,4-trimethoxybenzene (2.00 g, 11.9 mmol) in dry CH2Cl2 (20 mL). The resulting solution was heated to reflux and stirred overnight. After cooling to room temperature, the solution was washed with saturated Na2S2O3 aqueous solution (15 mL), and the aqueous layer was extracted with CH2Cl2 (2×15 mL). The combined organic extracts were dried over MgSO4 and evaporated. The crude product was purified by silica gel column chromatography (10% EtOAc / hexane) to obtain 2,4,5-trimethoxybromobenzene (2.61 g, 10.6 mmol, 89%) as a colorless solid. Mp.56–58°C; IR : =2999,2942,2843,1505,1451,1378,1204,1166,1022,838,799; 1 H NMR (300 MHz, chloroform-d) δ7.02 (s, 1H, H6), 6.55 (s, 1H, H3), 3.87 (s, 3H, C4-OCH3), 3.85 (s, 3H, C2-OCH3), 3.82 (s, 3H, C5-OCH3) ppm; 13 C NMR (76MHz, chloroform-d) δ150.3(C2),149.2(C4),143.8(C5),116.5(C6),101.1(C1),99.0(C3), 57.2 (C2-OCH3), 56.7 (C5-OCH3), 56.3 (C4-OCH3) ppm; MS (ESI+): m / z (%) = 246.1 (100) [M (Br 79 )+H] + ,248.1(98)[M(Br 81 )+H] + The analysis data are consistent with the literature.
[22]
[0170] [2-(Benzyloxy)-6-pentadecylphenyl](2,4,5-trimethoxyphenyl)methanone 3c
[0171] The title compound was synthesized from 2,4,5-trimethoxybromobenzene 2b (258 mg, 1.05 mmol) and methyl 2-benzyloxy-6-pentadecylbenzoate 1 (430 mg, 0.95 mmol) according to the general procedure. The resulting solution was stirred at room temperature for 1 h, and the crude product was purified by silica gel column chromatography (10-50% EtOAc / hexane) to produce [2-(benzyloxy)-6-pentadecylphenyl] (2,4,5-trimethoxyphenyl)methanone 3b (264 mg, 448 μmol, 47%) as a light yellow solid. Mp. 53.5–55 °C; IR : 2923,2852,1599,1579,1511,1464,1272,1213,1029,739; 1 H NMR (300 MHz, CHLOROFORM-d) δ7.38 (s, 1H, H6), 7.22–7.16 (m, 4H, H4′, Bn-H3, Bn-H4, Bn-H5), 7.07–7.02 (m, 2H, Bn-H2, Bn-H6), 6.86 (dd, J=7.7, 0.9 Hz, 1H, H5′), 6.75 (dd, J=8.3, 0.9 Hz, 1H, H3′), 6.41 (s, 1H, H3), 4.96 (s, 2 H,Bn-CH2),3.92(s,3H,C2-OCH3 / C4-OCH3),3.82(s,3H,C5-OCH3),3.49(s,3H,C2-OCH3 / C4-OCH3),2.55– 2.48(m,2H,H1“),1.54–1.48(m,2H,H2“),1.27–1.19(m,24H,H3“–H14“),0.88(t,J=7.0Hz,3H,H15“)ppm; 13 C NMR (76MHz, chloroform-d) δ194.4(C=O),156.0(C2 / C4),155.2(C2'),154.1(C2 / C4),143.1(C5),140.9(C6'),137.1(Bn-C1),133.1( C1'),128.8(C4'),128.1(2C,Bn-C3,Bn-C5),127.4(Bn-C4),126.7(2C,Bn-C2,Bn-C6),122.0(C5'),120.7(C1),113.8(C6),1 09.3(C3'),97.3(C3),70.0(Bn-CH2),56.5(C2-OCH3 / C4-OCH3),56.3(C5-OCH3),56.0(C2-OCH3 / C4-OCH3),33.0(C1″),31.9( C13"),31.0(C2"),29.7(6C),29.6,29.5,29.4,29.3,22.7(C14"),14.1(C15")ppm; MS(ESI+): m / z(%)=555.5(100)[M–OMe+H] + ,587.7(29)[M+H] + ; HRMS (ESI+): found (M+H) + 589.3882, C 38 H 53 O5(M+H) + Requires 589.3888.
[0172] [2-(Benzyloxy)-6-pentadecylphenyl](2-benzyloxyphenyl)methanone 3c
[0173] A suspension of 2-bromophenol (611 μL, 5.78 mmol) and K2CO3 (1.20 g, 8.70 mmol) in acetone (10 mL) was stirred at reflux for 10 min under a nitrogen atmosphere. Benzyl bromide (1.03 mL, 8.70 mmol) was then added dropwise, and the mixture was stirred at reflux for 3 h. After cooling to room temperature, CH2Cl2 (15 mL) was added, and the mixture was washed with water and brine (15 mL each). The organic layer was dried with MgSO4 and evaporated. The crude product was purified by silica gel column chromatography (5% EtOAc / hexane) to obtain 2-benzyloxybromobenzene 2c (1.29 g, 4.90 mmol, 85%) as a light yellow oil. IR :3064,2870,1586,1476,1441,1379,1276,1051,1029,742; 1 H NMR (300MHz, chloroform-d) δ7.55(dd,J=7.9,1.6Hz,1H,H6),7.49–7.46(m,2H,Bn-H2,Bn-H6),7.41–7.35(m,2H,Bn-H3,Bn-H5),7.34–7.31(m,1H ,Bn-H4),7.22(ddd,J=8.2,7.4,1.6Hz,1H,H4),6.92(dd,J=8.3,1.4Hz,1H,H3),6.85(td,J=7.9,1.4Hz,1H,H5),5.15(s,2H,Bn-CH2)ppm; 13 C NMR (76MHz, chloroform-d) δ155.0(C2),136.5(Bn-C1),133.4(C6),128.5(2C,Bn-C3,Bn-C5),128.4(C4),127.9(Bn-C4),12 7.0 (2C, Bn-C2, Bn-C6), 122.1 (C5), 113.9 (C3), 112.5 (C1), 70.8 (Bn-CH2) ppm; MS (ESI+): m / z (%) = 277.0 (100) [M (Br 79 )+NH4] + ,279.0(78)[M(Br 81 )+NH4] + The analysis data are consistent with the literature.
[23]
[0174] The title compound was synthesized from 2-benzyloxybromobenzene 2c (275 mg, 1.05 mmol) and methyl 2-benzyloxy-6-pentadecylbenzoate 1 (430 mg, 0.95 mmol) using synthesized 2-benzyloxybromobenzene according to the general procedure. The resulting solution was stirred at room temperature for 48 h, and the crude product was purified by silica gel column chromatography (2.5-5% EtOAc / hexane) to produce [2-(benzyloxy)-6-pentadecylphenyl] (2-benzyloxyphenyl)methanone 3c (57.5 mg, 94.5 μmol, 10%) as a colorless oil. IR (v / cm -1 ): 2923, 2853, 1653, 1595, 1580, 1450, 1379, 1297, 1052, 925, 750; 1 H NMR(500MHz, chloroform-d)δ7.74(d,J=7.7Hz,1H,H6),7.42(t,J=7.9Hz,1H,H4),7.25–7.21(m,3H,Bn-H3,Bn-H5,Bn'-4), 7.17–7.13(m,4H,H4',Bn-4,Bn'-3,Bn'-5),7.03–7.01(m,3H,H5,Bn-H2,Bn-H6),6.98–6.93(m,3H,H3,Bn'-H2,Bn' -H6),6.77(d,J=7.9Hz,1H,H5'),6.67(d,J=7.9Hz,1H,H3'),4.86(s,2H,Bn-CH2),4.84(s,2H,Bn'-CH2),2.49(dd, J=9.2,7.3Hz,2H,H1“),1.46(p,J=7.3Hz,2H,H2“),1.28–1.16(m,24H,H3“–H14“),0.88(t,J=6.9Hz,3H,H15“)ppm; 13C NMR (126MHz, chloroform-d) δ196.7(C=O),158.2(C2),155.6(C2'),141.8(C6),136.9(Bn'-C1),136.2(Bn-C1),133.5(C4),132.1(C1'),131 .6(C6),129.6(C1),129.4(C4'),128.2(2C,Bn-C3,Bn-C5),128.1(2C,Bn'-C3,Bn'-C5),127.5(Bn-C4),127.4(Bn'-C4),127.1(2C,B n-C2,Bn-C6),126.8(2C,Bn'-C2,Bn'-C6),122.2(C5'),120.6(C5),113.0(C3),109.4(C3'),70.3(Bn-CH2),69.9(Bn'-CH2),33.1( C1″),31.9(C13″),31.2(C2″),29.7(6C),29.6,29.5,29.4,29.3,22.7(C14″),14.1(C15″)ppm; MS(ESI+): m / z(%)=605.5(100)[M+H] + ,627.5(53)[M+Na] + ; HRMS (ESI+): found (M+H) + 605.3976, C 42 H 53 O3(M+H) + Requires 605.3989.
[0175] General procedure for the synthesis of hydroxybenzophenones 4a-c
[0176] Palladium on activated carbon (10 wt%) was added to a solution of the corresponding benzophenone 3a-c dissolved in a mixture of MeOH / EtOAc (10 / 1) under nitrogen atmosphere. The flask was purged with hydrogen and the suspension was stirred at room temperature overnight. After filtration, the residue was washed with MeOH and EtOAc (50 mL each), and the solvent was evaporated to give the desired products 4a-c.
[0177] (2-Pentadecyl-6-hydroxyphenyl)(2,5-dimethoxyphenyl)methanone 4a
[0178] The title compound was synthesized from [2-(benzyloxy)-6-pentadecylphenyl](2,5-dimethoxyphenyl)methanone 3a (217 mg, 384 μmol) using Pd / C (10 wt%, 22.0 mg, 20.1 μmol) and MeOH / EtOAc (10 / 1, 15 mL) according to the general procedure. The product 4a (181 mg, 380 μmol, 99%) was obtained as a light brown solid. Mp. 45–47 °C; IR : 3362,2922,2852,1606,1582,1494,1463,1278,1223,1046,813,722; 1 H NMR (300MHz, chloroform-d) δ9.32 (s, 1H, OH), 7.30 (dd, J = 7.5, 8.3Hz, 1H, H4'), 7.01 ( dd,J=9.0,3.1Hz,1H,H4),6.91–6.85(m,3H,H3,H6,H5'),6.69(dd,J=7.5,1.2 Hz,1H,H3'),3.74(s,3H,C5-OCH3),3.70(s,3H,C2-OCH3),2.26(dd,J=9.8,6. 3Hz,2H,H1“),1.34–1.14(m,26H,H2“–H14“),0.88(t,J=6.5Hz,3H,H15“)ppm; 13 C NMR (76 MHz, chloroform-d) δ 200.9 (C=O), 160.3 (C6'), 153.4 (C5), 151.5 (C2), 145.0 (C2'), 134.0 (C4'), 131.2 (C1), 122.6 (C1'), 121.6 (C3'), 118.2 (C4), 115.4 (C5'), 114.4 (C6), 113.2 (C3),56.4(C2-OCH3),55.8(C5-OCH3),34.7(C1″),32.4(C2″),31.9(C13″),29.7(6C),2 9.6,29.5,29.4,29.3,22.7(C14″),14.1(C15″)ppm; MS(ESI+): m / z(%)=469.4(100)[M+H] + ,491.4(16)[M+Na] + ; HRMS (ESI+): found (M+H) + 469.3303, C 30 H 45 O4(M+H) + Requires 469.3312.
[0179] (2-Pentadecyl-6-hydroxyphenyl)(2,4,5-trimethoxyphenyl)methanone 4b
[0180] The title compound was synthesized from [2-(benzyloxy)-6-pentadecylphenyl](2,4,5-trimethoxyphenyl)methanone 3b (243 mg, 413 μmol) using Pd / C (10 wt%, 25.0 mg, 23.5 μmol) and MeOH / EtOAc (10 / 1, 20 mL) according to the general procedure. The product 4b (190 mg, 381 μmol, 92%) was obtained as a light brown solid. Mp. 78–81 °C; IR : 3314,2922,2852,1581,1513,1462,1354,1270,1212,1025,807; 1 H NMR (300MHz, chloroform-d) δ9.18(s,1H,OH),7.25(t,J=7.9Hz,1H,H4'),7.02(s,1H,H6),6.84(dd,J=8.2,1.1Hz,1H,H5'),6.71(dd,J=7.6 1.1Hz,1H,H3'),6.49(s,1H,H3),3.96(s,3H,C2-OCH3 / C4-OCH3),3.82(s,3H,C5-OCH3),3.68(s,3H,C2- OCH3 / C4-OCH3),2.36–2.30(m,2H,H1“),1.36–1.12(m,26H,H2“–H14“),0.88(t,J=7.0Hz,3H,H15“)ppm; 13 C NMR (76 MHz, chloroform-d) δ 198.7 (C=O), 158.1 (C6'), 154.1 (C2 / C4), 153.7 (C2 / C4), 143.9 (C2'), 143.2 (C5), 132.8 (C4'), 124.6 (C1'), 121.4 (C3'), 121.4 (C1), 114.9 (C5'), 113.1 (C6), 97.2 (C3), 56.6 (C2 -OCH3 / C4-OCH3),56.5(C5-OCH3),56.1(C2-OCH3 / C4-OCH3),34.4(C1″),32.2(C2″),31.9(C13″), 29.7(6C),29.5(2C),29.3(2C),22.7(C14″),14.1(C15″)ppm; MS(ESI+): m / z(%)=499.5(100)[M+H] + ,521.4(6)[M+Na] + ; HRMS (ESI+): found (M+H)+ 499.3409, C 31 H 47 O5(M+H) + Requires 499.3418.
[0181] [2-(Hydroxy)-6-pentadecylphenyl](2-hydroxyphenyl)methanone 4c
[0182] The title compound was synthesized from [2-(benzyloxy)-6-pentadecylphenyl](2-benzyloxyphenyl)methanone 3c (44.6 mg, 74.0 μmol) using Pd / C (10 wt%, 5.00 mg, 4.70 μmol) and MeOH / EtOAc (10 / 1, 4 mL) according to the general procedure. The product 4c (26.3 mg, 61.9 μmol, 84%) was obtained as a light yellow oil. IR (v / cm -1 ): 3392,2923,2853,1625,1583,1463,1307,1283,1110,939,756; 1 H NMR (300 MHz, chloroform-d) δ 12.07 (s, 1H, C2-OH), 7.48 (ddd, J = 8.5, 7.2, 1.7 Hz, 1H, H4), 7.31 (dd, J = 8.0, 1.7 Hz, 1H, H6), 7.25 (t, J = 7.9 Hz, 1H, H4'), 7.03 (dd, J = 8.5, 1.1 Hz, 1H, H3), 6.87 (d, J = 7.7 Hz, 1H, H3), 6 .83–6.79(m,1H,H5),6.73(dd,J=8.2,1.0Hz,1H,H3'),5.69(s,1H,C2'-OH),2.42(dd,J=9.0,6.7Hz, 2H,H1“),1.45(p,J=6.8Hz,2H,H2”),1.33–1.14(m,24H,H3“–H14“),0.86(t,J=6.7Hz,3H,H15“)ppm; 13C NMR (76 MHz, chloroform-d) δ 203.8 (C=O), 162.7 (C2), 152.8 (C2'), 142.0 (C6'), 137.0 (C4), 133.2 (C6), 131.0 (C4'), 125.1 (C1'), 121.8 (C5'), 120.7 (C1), 119.2 (C5), 118.2 ( C3),113.8(C3'),33.5(C1″),31.9(C13″),31.1(C2″),29.7(3C),29.6(3C),29.4, 29.3, 29.2(2C), 22.7(C14″), 14.1(C15″)ppm; MS (ESI–): m / z (%) = 423.4 (100) [M–H] – ; HRMS (ESI+): found (M+H) + 425.3047, C 28 H 41 O3(M+H) + Requires 425.3050.
[0183] (2-Hydroxy-5-methoxyphenyl)(2-hydroxy-6-pentadecylphenyl)methanone 5
[0184] At room temperature and nitrogen atmosphere, AlCl3 (9.05 mg, 67.9 μmol) and pyridine (16.4 μL, 203.6 μmol) were added to a dry toluene (1 mL) solution of (2-pentadecyl-6-hydroxyphenyl) (2,5-dimethoxyphenyl) ketone (15.9 mg, 33.9 μmol). The resulting solution was stirred at reflux for 5 d, with AlCl3 (9.05 mg, 67.9 μmol) and pyridine (16.4 μL, 203.6 μmol) added every day. The mixture was then cooled to room temperature. Aqueous HCl solution (2 m, 5 mL) was added, and the mixture was extracted with diethyl ether (3 × 5 mL). The combined organic extracts were dried over Na2SO4 and evaporated. The crude product was purified by silica gel column chromatography (17% EtOAc / cyclohexane) to obtain the product (8.60 mg, 18.9 μmol, 56%) as a brown oil 5. IR : 3377,2922,2853,1612,1484,1463,1284,1040,791; 1 H NMR (300 MHz, chloroform-d) δ 11.68 (s, 1H, C2'-OH), 7.27 (t app ,J app=7.9Hz,1H,H4),7.13(dd,J=9.1,3.0Hz,1H,H4'),7.00(d,J=9.1Hz,1H,H3'),6.88(d,J=7.5Hz,1H,H5),6.76(m,2H,H3,H6'),5.59(s,br,1H,C 2-OH),3.63(s,3H,C5'-OCH3),2.46–2.43(m,2H,H1″),1.49–1.44(m,2H,H2″),1.25–1.15(m,24H,H3″–H14″),0.88(t,J=6.7Hz,3H,H15″)ppm; 13 C NMR (76 MHz, chloroform-d) δ 203.3 (C=O), 157.2 (C2'), 152.9 (C2), 151.9 (C5'), 142.1 (C6), 131.2 (C4), 124.9 (2C, C1, C4'), 121.9 (C5), 120.3 (C1'), 119.2 (C3'), 115.4 (C6'), 113. 9(C3),55.8(C5'-OCH3),33.6(C1″),31.9(C13″),31.2(C2″),29.7(4C),29.6(2C),29 .4(2C),29.2(2C),22.7(C14″),14.1(C15″)ppm; MS(ESI+): m / z(%)=455.4(100)[M+H] + ,477.3(37)[M+Na] + ; HRMS (ESI+): found (M+H) + 455.3159, C 29 H 43 O4(M+H) + Requires 455.3156.
[0185] (2-pentadecyl-6-hydroxyphenyl)(2-hydroxy-4,5-dimethoxyphenyl)methanone
[0186] Under nitrogen atmosphere at -78°C, a solution of BCl3 in CH2Cl2 (1 m, 29.0 μL, 29.0 μmol) was added to a solution of (2-pentadecyl-6-hydroxyphenyl)(2,4,5-trimethoxyphenyl)methanone 4b (13.3 mg, 26.7 μmol) in dry CH2Cl2 with stirring. The solution was kept at this temperature for 8 h and then left at room temperature overnight. Stirring was continued at room temperature for 4 d, with CH2Cl2 containing BCl3 (1 M, 29.0 μL, 29.0 μmol) added daily. Aqueous NaOH solution (1 m, 1 mL) was added and the mixture was stirred for 1 h. Aqueous HCl solution (2 m, 1 mL) was then added and the mixture was extracted with CH2Cl2 (2×3 mL). The combined organic extracts were dried over Na2SO4 and evaporated. The crude product was purified by silica gel column chromatography (25% EtOAc / cyclohexane) to afford (2-pentadecyl-6-hydroxyphenyl)(2-hydroxy-4,5-dimethoxyphenyl)methanone (8.90 mg, 18.3 μmol, 69%) as a yellow solid 6. Mp. 86.3-88°C; IR : 3439,2922,2852,1626,1441,1238,1204,1164,1126,800; 1 HNMR (300 MHz, chloroform-d) δ12.58 (s, 1H, C2-OH), 7.27 (t app ,J app =7.9Hz,1H,H4'),6.88(dd,J=7.7,1.0Hz,1H,H3'),6.79(dd,J=8.1,1.0Hz, 1H,H5'),6.65(s,1H,H6),6.52(s,1H,H3),5.78(s,br,1H,C6'-OH),3.94(s, 3H,C4-OCH3),3.62(s,3H,C5-OCH3),2.47(t,J=7.8Hz,2H,H1“),1.50–1.42 (m,2H,H2“),1.30–1.16(m,24H,H3“–H14“),0.86(t,J=6.9Hz,3H,H15“)ppm; 13C NMR (76 MHz, chloroform-d) δ 200.8 (C=O), 161.0 (C2), 157.6 (C4), 153.0 (C6'), 142.2 (C5), 141.8 (C2'), 131.1 (C4'), 125.0 (C1'), 121.8 (C3'), 114.0 (C5'), 113.4 (C6), 112.8 (C1), 100.5 (C 3),56.4(C5-OCH3),56.3(C4-OCH3),33.6(C1″),31.9(C13″),31.3(C2″),29.7(5C),29.6 (2C),29.5,29.4,29.3,22.7(C14″),14.1(C15″)ppm; MS(ESI+): m / z(%)=485.4(100)[M+H] + ,507.3(22)[M+Na] + ; HRMS (ESI+): found (M+H) + 485.3258, C 30 H 45 O5(M+H) + Requires 485.3262.
[0187] 3-Pentadecylphenylbenzoate 8
[0188] To a stirred solution of 3-pentadecylphenol 7 (5.00 g, 16.42 mmol) in 2-methyl-THF (60 mL) triethylamine (4.58 mL, 32.84 mmol) and 4-dimethylaminopyridine (0.200 g, 1.64 mmol) were added, and the mixture was cooled to 0 ° C. Benzoyl chloride (2.54 g, 2.10 mL, 18.06 mmol) dissolved in 2-methyl-THF (20 mL) was slowly added to this cooled mixture, and the reaction mixture was warmed to room temperature and stirred for 2 h. After completion, the reaction was quenched with water (50 mL) and the mixture was extracted with EtOAc (3×10 mL). The combined organic extracts were washed with NaHCO aqueous solution (100 mL), then with brine (100 mL), then dried over MgSO, and the solvent was removed under reduced pressure. The crude product was purified by silica gel column chromatography (10% EtOAc / cyclohexane) to give 3-pentadecylphenylbenzoate 8 (5.96 g, 89%) as a white crystalline solid. Mp. 52.1-53.9°C; IR : 2918, 2846, 1731, 1585, 1238, 1144, 1079, 710; 1H NMR (400MHz, chloroform-d) δ8.25 (dd, J=8.3, 1.4Hz, 2H, H2′), 7.69–7.64 (m, 1H, H4′), 7.55(dd,J=8.3,7.0Hz,2H,H3′),7.36(td,J=7.6,1.5Hz,1H,H5),7.13(dd,J= 7.7,1.3Hz,1H,H4),7.10–7.05(m,2H,H2,H6),2.68(t,J=7.7Hz,2H,H1″),1.7 5–1.63(m,2H,H2″),1.30(m,24H,H3″-H14″),0.92(t,J=5.7Hz,3H,H15″)ppm; 13 C NMR (101 MHz, chloroform-d) δ 165.2 (C=O), 151.0 (C1), 144.8 (C3), 133.5 (C4′), 130.2 (C2′), 129.7 (C1′), 129.2 (C5), 128.5 (C3′), 126.0 (C4), 121.6 (C2), 118.8 (C5), 35.8 (C1″), 32.0 (C13″), 31.3 (C2″), 29.7 (6C), 29.6 (1C), 29.5 (1C), 29.4 (1C), 29.3 (1C), 22.7 (C14″), 14.2 (C15″) ppm; HRMS (ESI+): found (M+H) + 409.3107, C 28 H 41 O2(M+H) + Requires 409.3101.
[0189] (2-Hydroxy-4-pentadecylphenyl)(phenyl)methanone 9
[0190] 3-Pentadecylphenylbenzoate 8 (0.20 g, 0.49 mmol) was dissolved in chlorobenzene (3 mL) in a microwave reactor tube. To this solution was added AlCl3 (0.16 g, 1.23 mmol). The tube was sealed and the reaction mixture was subjected to microwave irradiation (150 W, 160 ° C) for 30 min. After cooling to room temperature, the crude product was purified by column chromatography (5% EtOAc / cyclohexane) to give (2-hydroxy-4-pentadecylphenyl) (phenyl)methanone 9 (0.16 g, 78%) as an off-white solid. Mp.40.8-42.6 ° C; IR : 2912, 2848, 1626, 1600, 1470, 1334, 1223, 915, 765, 700; 1H NMR (400 MHz, CHLOROFORM-d) δ 12.19 (s, 1H, C2-OH), 7.72–7.67 (m, 2H, H2′), 7.62–7.56 (m, 1H, H4′), 7.54–7.50 (m, 3H, H3′ and H6), 6.93 (d, J = 1.6 Hz, 1H, H3), 6.72 (dd, J = 8.2, 1.7 Hz, 1H, H5), 2.65 (t, 2H, H1″), 1.73–1.60 (m, 2H, H2″), 1.30 (m, 24H, H3″-H14″), 0.91 (t, J = 5.6 Hz, 3H, H15″) ppm; 13 C NMR (101 MHz, chloroform-d) δ 201.1 (C=O), 163.5 (C2), 153.0 (C4), 138.2 (C1′), 133.5 (C6), 131.7 (C4′), 129.1 (C2′), 128.3 (C3′), 119.3 (C5), 117.8 (C3), 117.1 (C1), 36.3 (C1″), 32.0 (C13″), 30.7 (C2″), 29.7 (6C), 29.6 (1C), 29.5 (1C), 29.4 (1C), 29.3 (1C), 22.7 (C14″), 14.2 (C15″) ppm; HRMS (ESI+): found (M+H) + 409.3096, C 28 H 41 O2(M+H) + Requires 409.3101.
[0191] (2-Hydroxy-4-pentadecylphenyl)(2-hydroxyphenyl)methanone 10
[0192] To a 15 mL scintillation vial was added (2-hydroxy-4-pentadecylphenyl)(phenyl)methanone 9 (0.30 g, 0.73 mmol), K2S2O8 (0.40 g, 1.47 mmol), [Ru(p-isopropyltoluene)Cl2]2 (11 mg, 0.018 mmol), TFAA (5.0 mL) and TFA (2.0 mL). The reaction was sealed with a polytetrafluoroethylene-lined lid and heated at 80 ° C and monitored by TLC. After completion, EtOAc was added to dilute the reaction mixture, and saturated NaHCO3 aqueous solution was added to neutralize TFA and TFAA. The organic layer was then dried over anhydrous Na2SO4 and concentrated in vacuo. Finally, the residue was purified by silica gel column chromatography (5% EtOAc / hexanes) to obtain (2-hydroxy-4-pentadecylphenyl)(2-hydroxyphenyl)methanone 10 (220 mg, 72%) as a white crystalline solid. Mp.31.4-32.6 ° C; IR : 3403,2921,2852,1599,1573,1337,1229,755,699; 1 H NMR (300 MHz, chloroform-d) δ 10.86 (s, 1H, C2-OH), 10.52 (s, 1H, C2′-OH), 7.61 (dd, J=8.0, 1.8 Hz, 1H, H6′), 7.56–7.41 (m, 2H, H4′ and H6), 7.07 (d, J=8.4 Hz, 1H, H3′), 6.93 (d, J= 7.7Hz,1H,H5′),6.89(s,1H,H3),6.74(dd,J=8.3,1.8Hz,1H,H5),2.62(t,2H,H1″) ,1.67-1.61(m,2H,H2″),1.26(m,24H,H3″-H14″),0.87(t,J=5.7Hz,3H,H15″)ppm; 13 C NMR (75 MHz, chloroform-d) δ 201.8 (C=O), 162.3 (C2), 161.4 (C2′), 152.8 (C4), 135.5 (C4′), 133.1 (C6), 132.9 (C6′), 120.1 (C1′), 119.5 (C5), 118.7 (C5′), 118.5 (C3′), 118.0 (C3), 117.5 (C1), 36.2 (C1″), 31.9 (C13″), 30.6 (C2″), 29.7 (6C), 29.6 (1C), 29.5 (1C), 29.4 (1C), 29.3 (1C), 22.7 (C14″), 14.1 (C15″) ppm; HRMS (ESI+): found (M+H) + 425.3058, C 28 H 41 O4(M+H) + Requires 425.3050.
[0193] 3-Pentadecylphenyl acetate 11
[0194] Triethylamine (1.83 mL, 13.14 mmol) and 4-dimethylaminopyridine (0.08 g, 0.66 mmol) were added to a stirred solution of 3-pentadecylphenol 7 (2.00 g, 6.57 mmol) in 2-methyl-THF (20 mL), and the mixture was cooled to 0 ° C. Acetyl chloride (0.62 g, 0.56 mL, 7.88 mmol) dissolved in 2-methyl-THF (5 mL) was slowly added to this cooled mixture, and the reaction mixture was slowly warmed to room temperature and stirred at room temperature for 2 h. The reaction was quenched with water (20 mL) and the mixture was extracted with EtOAc (3 × 10 mL). The combined organic extracts were washed with NaHCO aqueous solution (50 mL), then washed with brine (50 mL), then dried with MgSO, and the solvent was removed under reduced pressure. The crude product was purified by silica gel column chromatography (10% EtOAc / cyclohexane) to give 3-pentadecylphenyl acetate 11 (2.15 g, 93%) as a low melting white solid. Mp. 36.9-37.5°C; IR : 2914, 2848, 1757, 1612, 1587, 1204, 1142, 1015, 952, 694; 1 HNMR (400 MHz, chloroform-d) δ7.34–7.27 (m, 1H, H5), 7.09 (d, J = 7.7 Hz, 1H, H4), 6.96 (d, J = 1.3 Hz, 1H, H2), 6.97–6.93 (m, 1H, H6), 2.66 (t, 2H, H1″), 2.32 (s, 3H, H1′), 1.73–1.60 (m, 2H, H2″), 1.32 (m, 24H, H3″-H14″), 0.94 (t, J = 5.7 Hz, 3H, H15″) ppm; 13 C NMR (101 MHz, chloroform-d) δ 169.5 (C=O), 150.7 (C1), 144.7 (C3), 129.1 (C5), 125.9 (C4), 121.4 (C2), 118.7 (C6), 35.8 (C1″), 32.0 (C13″), 31.3 (C2″), 29.8 (5C) 29.7 (1C), 29.6 (1C), 29.5 (1C), 29.4 (1C), 29.3 (1C), 22.8 (C14″), 21.1 (C1′), 14.2 (C15″) ppm; HRMS (ESI+): found (M+Na) + 369.2761, C 23 H 38 O2Na(M+Na) + Requires 369.2764.
[0195] 1-(2-Hydroxy-4-pentadecylphenyl)ethanone 12
[0196] 3-Pentadecylphenyl acetate 11 (0.40 g, 1.16 mmol) was dissolved in chlorobenzene (6 mL) in a microwave reactor tube. To this solution was added AlCl3 (0.38 g, 2.88 mmol). The tube was sealed and the reaction mixture was subjected to microwave irradiation (150 W, 160 ° C) for 30 min. After cooling, the crude product was purified by column chromatography (10% EtOAc / cyclohexane) to give 1-(2-hydroxy-4-pentadecylphenyl)ethanone 12 (0.39 g, 99%) as a light brown solid. Mp. 49.1-50.5 ° C; IR : 2915, 2848, 1636, 1573, 1471, 1365, 1249, 799, 717; 1 H NMR (400 MHz, CHLOROFORM-d) δ 12.31 (s, C2′-OH), 7.65 (d, J = 8.2 Hz, 1H, H6′), 6.81 (d, J = 1.6 Hz, 1H, H3′), 6.74 (dd, J = 8.2, 1.7 Hz, 1H, H5′), 2.67–2.54 (m, 5H, H1 and H1″), 1.70–1.57 (m, 2H, H2″), 1.40–1.20 (m, 24H, H3″-H14″), 0.89 (t, J = 5.5 Hz, 3H, H15″) ppm; 13 C NMR (101 MHz, chloroform-d) δ 203.8 (C=O), 162.5 (C2′), 153.0 (C4′), 130.6 (C6′), 119.6 (C5′), 117.7 (C3′), 36.2 (C1″), 31.9 (C13″), 30.7 (C2″), 29.7 (6C), 29.6 (1C), 29.5 (1C), 29.4 (1C), 29.3 (1C), 26.5 (C1), 22.7 (C14″), 14.1 (C15″) ppm; HRMS (ESI+): found (M+H) + 347.2942, C 23 H 39 O2(M+H) + Requires 347.2945. The data are consistent with those reported in the literature.
[24]
[0197] (E)-1-(2-Hydroxy-4-pentadecylphenyl)-3-phenylprop-2-en-1-one 13a
[0198] 1-(2-hydroxy-4-pentadecylphenyl)ethanone 12 (0.097 g, 0.28 mmol), benzaldehyde (28 μL, 30 mg, 0.28 mmol), sodium hydroxide (34 mg, 0.85 mmol) and methanol (2 mL) were added to a round-bottom flask (10 mL) equipped with a magnetic stirrer. The pale yellow mixture was refluxed until the color turned orange (about 4 h). The mixture was poured into ice water and extracted with ethyl acetate (3×10 mL). The organic layer was dried, filtered, and the solvent was removed in vacuo with Na2SO4. The crude product was subjected to column chromatography (5% EtOAc / cyclohexane) to supply ((E)-1-(2-hydroxy-4-pentadecylphenyl)-3-phenylprop-2-ene-1-one 13a (0.085 g, 67%) as a bright yellow solid. Mp.54.7-56.4°C; IR : 2915, 2849, 1640, 1618, 1350, 1204, 1148, 788, 738; 1 H NMR (400 MHz, CHLOROFORM-d) δ 12.91 (s, 1H, C2″-OH), 7.93 (d, J = 15.5 Hz, 1H, H3), 7.85 (d, J = 8.3 Hz, 1H, H6″), 7.71–7.63 (m, 3H, H2 and H2′), 7.50–7.43 (m, 3H, H3′ and H4′), 6.87 (d, J = 1.5 Hz, 1H, H3″), 6.79 (dd, J = 8.2, 1.7 Hz, 1H, H5″), 2.64 (t, 2H, H1″′), 1.90–1.47 (m, 2H, H2″′), 1.28 (m, 24H, H3″′-H14″′), 0.90 (t, J = 5.7, 3H, H15″′) ppm; 13 C NMR (101 MHz, chloroform-d) δ 193.1 (C=O), 163.8 (C2″), 153.1 (C4″), 144.9 (C3), 134.7 (C1′), 130.8 (C4′), 129.5 (C6″), 129.0 (C3′), 128.6 (C2′), 120.3 (C2), 119.5 (C5″), 118.0 (C3″), 36.3 (C1″′), 31.9 (C13″′), 30.7 (C2″′), 29.7 (6C), 29.6 (1C), 29.5 (1C), 29.4 (1C), 29.3 (1C), 22.7 (C14″′), 14.1 (C15″′) ppm; HRMS (ESI+): found (M+H) + 435.3259, C 30 H 43 O2(M+H) + Requires 435.3258.
[0199] 3-Hydroxy-7-pentadecyl-2-phenyl-4H-chromen-4-one 13b
[0200] ((E)-1-(2-Hydroxy-4-pentadecylphenyl)-3-phenylprop-2-en-1-one (0.156 g, 0.36 mmol) was dissolved in a 50 mL round bottom flask containing methanol (10 mL). To this stirred mixture was added sodium hydroxide (0.5 N, 2.7 mL) and hydrogen peroxide (30%, 220 μL), and the mixture was stirred at room temperature for 2 h, when the color turned orange. The reaction was acidified with aqueous HCl (15 mL) and the mixture was extracted with ethyl acetate (3×20 mL). The organic layer was dried over Na2SO4, filtered, and the solvent was removed under reduced pressure. The crude product was subjected to column chromatography (10% EtOAc / hexanes) to give 3-hydroxy-7-pentadecyl-2-phenyl-4H-chromen-4-one 13b (0.141 g, 88%) as a yellow solid. Mp. 81.2-83.7°C; IR : 3406,2918,2841,1643,1612,1363,1203,1149,747; 1 H NMR (500 MHz, CHLOROFORM-d) δ 8.26 (dd, J = 8.8, 1.5 Hz, 2H, H2′), 8.15 (d, J = 8.1 Hz, 1H, H5), 7.54 (t, J = 7.6, Hz, 2H, H3′), 7.50–7.44 (m, 1H, H4′), 7.40 (d, J = 1.4 Hz, 1H, H8), 7.28–7.22 (m, 2H, H6 and C3-OH), 2.76 (t, J = 7.7, Hz, 1H, H1″), 1.75–1.65 (m, 1H, H2″), 1.41–1.20 (m, 24H, H3″-H14″), 0.88 (t, J = 6.9, Hz, 3H, H15″) ppm; 13 C NMR (126 MHz, chloroform-d) δ 173.4 (C=O), 155.7 (C8a), 150.1 (C7), 144.5 (C2), 138.3 (C3), 131.3 (C1′), 130.0 (C4′), 128.6 (C3′), 127.7 (C2′), 125.6 (C6), 125.2 (C5), 118.6 (C4a), 117.3 (C8), 36.2 (C1″), 31.9 (C13″), 30.9 (C2″), 29.7 (5C), 29.6 (1C), 29.5 (2C), 29.4 (1C), 29.2 (1C), 22.7 (C14″), 14.1 (C15″) ppm; HRMS (ESI+): found (M+H)+ 449.3054, C 30 H 41 O3(M+H) + Requires 449.3050.
[0201] 3-Pentadecylphenyl-2-fluorobenzoate 15
[0202] Triethylamine (1.37 g, 1.89 mL, 13.58 mmol) and 4-dimethylaminopyridine (0.083 g, 0.68 mmol) were added to a stirred solution of 3-pentadecylphenol 7 (2.07 g, 6.69 mmol) in 2-methyl-THF (20 mL), and the mixture was cooled to 0 ° C. 2-Fluorobenzoyl chloride (1.19 g, 0.89 mL, 7.48 mmol) dissolved in 2-methyl-THF (5 mL) was slowly added to this cooled mixture, and the reaction mixture was slowly warmed to room temperature and stirred at room temperature for 2 h. The reaction was quenched with water (20 mL) and the mixture was extracted with EtOAc (3 × 10 mL). The combined organic extracts were washed with NaHCO aqueous solution (50 mL), then washed with brine (500 mL), then dried with MgSO, and the solvent was removed under reduced pressure. The crude product was purified by silica gel column chromatography (10% EtOAc / cyclohexane) to give 3-pentadecylphenyl-2-fluorobenzoate 15 (2.84 g, 98%) as a white crystalline solid. Mp. 57.2-58.9° C.; IR : 2932, 2813, 1702, 1596, 1214, 1130, 1081, 747, 712; 1 H NMR (400 MHz, chloroform-d) δ 8.14 (td, J = 7.5, 7.5, 1.8 Hz, 1H, H6′), 7.68–7.57 (m, 1H, H4′), 7.36 (td, J = 7.4, 7.4, 1.3 Hz, 1H, H5), 7.35–7.26 (m, 1H, H5′), 7.24 (ddd, J = 10.8, 8.3, 1.1 Hz, 1H, H3′ ),7.13(dd,J=7.7,1.3Hz,1H,H4),7.10(d,J=1.3Hz,1H,H2),7.09–7.06(m,1H,H6),2.68(t ,2H,H1″),1.73–1.62(m,2H,H2″),1.31(m,24H,H3″-H14″),0.92(t,J=5.7Hz,3H,H15″)ppm; 13C NMR (101 MHz, chloroform-d) δ 163.6 (C=O), 162.9 (C2′), 162.8 (C2′), 161.0 (C2′), 150.6 (C1), 144.8 (C3), 135.1 (C4′), 132.5 (C6′), 129.2 (C5), 126.1 (C4), 124.1 (C5′), 124.1, 121.5 (C2), 1 18.8(C6),117.3(C1′),117.1(C3′),35.8(C1″),32.0(C13″),31.3(C2″),29.7(6C),29.6(1C),29.5(1C),29.4(1C),29.3(1C),22.8(C14″),14.2(C15″)ppm; HRMS(ESI+): found (M+Na) + 449.2881, C 28 H 39 FNaO2(M+Na) + Requires 449.2886.
[0203] (2-Fluorophenyl)(2-hydroxy-4-pentadecylphenyl)methanone 16
[0204] 3-Pentadecylphenyl-2-fluorobenzoate 15 (0.101 g, 2.37 mmol) was dissolved in chlorobenzene (12 mL) in a microwave reactor tube. To this solution was added AlCl3 (0.79 g, 5.92 mmol). The tube was sealed and the reaction mixture was subjected to microwave irradiation (150 W, 160 ° C) for 30 min. After cooling, the crude product was purified by column chromatography (5% EtOAc / cyclohexane) to give (2-fluorophenyl) (2-hydroxy-4-pentadecylphenyl) ketone 16 (0.85 g, 84%) as an off-white solid. Mp. 41.4-43.2 ° C; IR : 2916, 2846, 1614, 1454, 1333, 1217, 1162, 914, 759; 1 H NMR (400 MHz, CHLOROFORM-d) δ 12.09 (s, OH, C2-OH), 7.58–7.43 (m, 2H, H4′ and H6′), 7.38–7.25 (m, 2H, H3′ and H6), 7.21 (ddd, J = 9.5, 8.3, 1.0 Hz, 1H, H5′), 6.91 (d, J = 1.6 Hz, 1H, H3), 6.71 (dd, J = 8.3, 1.7 Hz, 1H, H5), 2.64 (t, 2H, H1″), 1.74–1.59 (m, 2H, H2″), 1.30 (m, 24H, H3″-H14″), 0.91 (t, J = 5.8 Hz, 3H, H15″) ppm;13 C NMR (101 MHz, chloroform-d) δ 197.8 (C=O), 163.3 (C2-OH), 160.3 (C2′), 157.8 (C1′), 153.8 (C4), 133.3 (C6), 132.7 (C6′), 129.8 (C4′), 128.6 (C1), 124.4 (C3′), 119.7 (C4), 117.7 (C3), 116.1 (C5′), 36.4 (C1″), 32.0 (C13″), 30.6 (C2″), 29.8 (6C), 29.6 (1C), 29.5 (1C), 29.4 (1C), 29.3 (1C), 22.7 (C14″), 14.2 (C15″) ppm; HRMS (ESI+): found (M+H) + 427.3002, C 28 H 40 FO2(M+H) + Requires 427.3007.
[0205] 3-Pentadecyl-9H-xanthene-9-one 17
[0206] To a 25 mL round bottom flask was added (2-fluorophenyl)(2-hydroxyphenyl)methanone 16 (0.225 g, 0.53 mmol), K2CO3 (0.146 g, 1.05 mmol) and 5 mL of acetone at room temperature. The reaction mixture was heated at 50 °C for 4 h. The resulting mixture was cooled to room temperature, filtered and then extracted with CH2Cl2. The organic layer was dried over anhydrous Na2SO4 and the solvent was concentrated in vacuo. Finally, the residue was purified by silica gel column chromatography (5% EtOAc / cyclohexane) to give the desired 3-pentadecyl-9H-xanthene-9-one 17 (0.183 g, 86%) as a white solid. Mp. 75.2-76.4 °C; IR : 2915, 2848, 1663, 1606, 1463, 1431, 1344, 1179, 1149, 1109, 959, 758, 727; 1H NMR (400 MHz, chloroform-d) δ 8.34 (dd, J = 7.9, 1.7 Hz, 1H, H8), 8.24 (d, J = 8.2 Hz, 1H, H1), 7.70 (ddd, J = 8.7, 7.1, 1.8 Hz, 1H, H6), 7.47 (dd, J = 8.5, 1.0 Hz, 1H, H5), 7.36 (ddd, J = 8.1, 7.1, 1.1 Hz,1H,H7),7.28(d,J=1.3Hz,1H,H4),7.20(dd,J=8.2,1.6Hz,1H,H2),2.75(t,2H,H1′) ,1.76-1.64(m,2H,H2′),1.40-1.19(m,24H,H3′-H14′),0.88(t,J=5.8Hz,3H,H15′)ppm; 13 C NMR (101 MHz, chloroform-d) δ 177.0 (C=O), 156.3 (C4a), 156.1 (C10a), 151.3 (C3), 134.5 (C6), 126.7 (C8), 126.5 (C1), 124.8 (C2), 123.7 (C7), 121.9 (C8a), 119.8 (C9a), 117.9 (C5), 117.0 (C4), 36.2 (C1′), 31.9 (C13′), 30.9 (C2′), 29.7 (6C), 29.6 (1C), 29.5 (1C), 29.4 (1C), 29.3 (1C), 22.7 (C14′), 14.1 (C15′) ppm; HRMS (ESI+): found (M+H) + 407.2940,C 28 H 39 O2(M+H) + Requires 407.2945.
[0207] 1,8-Dihydroxy-3-pentadecyl-9H-xanthene-9-one 14
[0208] 3-pentadecyl-9H-xanthene-9-one 16 (0.54 g, 1.32 mmol), K2S2O8 (1.44 g, 5.31 mmol), [Ru(p-isopropyltoluene)Cl2]2 (11 mg, 20.2 mmol), TFAA (10.5 mL) and TFA (4.5 mL) were added to a 25 mL scintillation vial. The reaction was sealed with a polytetrafluoroethylene-lined lid, heated at 80 °C, and monitored by TLC. Upon completion, EtOAc was added to dilute the reaction mixture, and saturated NaHCO3 aqueous solution was added to neutralize TFA and TFAA. The organic layer was then dried over anhydrous Na2SO4 and concentrated in vacuo. Finally, the residue was purified by silica gel column chromatography (5% EtOAc / hexanes) to give 1-hydroxy-3-pentadecyl-9H-xanthene-9-one 14 (395 mg, 71%) as a white crystalline solid. Mp.93.7-95.9 °C; IR : 3401,2914,2849,1630,1597,1498,1319,1239,1077,1057,831,749,736; 1 HNMR (300MHz, chloroform-d) δ12.56 (s, 1H, C1-OH), 8.27 (dd, J = 8.0, 1.7 Hz, 1H, H8), 7.73 (ddd, J = 8.7, 7.1, 1.7 Hz, 1H, H6), 7.45 (dd, J = 7.5, 1.0 Hz, 1H, H5), 7.38 (ddd, J = 8.1, 7.1, 1.0 Hz, 1H,H7),6.77(d,J=1.4Hz,1H,H2),6.65(d,J=1.4Hz,1H,H4),2.67(t,J=7.7,Hz,2H,H1′) ,1.77–1.56(m,2H,H2′),1.31-1.19(m,24H,H3′-H14′),0.88(t,J=6.3Hz,3H,H15′)ppm; 13 C NMR (76 MHz, chloroform-d) δ 181.8 (C=O), 161.6 (C1), 156.2 (C4a), 156.2 (C10a), 154.0 (C3), 135.3 (C6), 126.0 (C8), 123.9 (C7), 120.7 (C8a), 117.8 (C5), 110.6 (C4), 107.2 (C9a), 106.8 (C2), 36.8 (C1′), 31.9 (C13′), 30.6 (C2′), 29.7 (6C), 29.5 (1C), 29.5 (1C), 29.4 (1C), 29.2 (1C), 22.7 (C14′), 14.1 (C15′) ppm; HRMS (ESI+): found (M+H) +423.2894, C 28 H 39 O3(M+H) + Required 423.2894. Into a 15 mL scintillation vial, add some 1-hydroxy-3-pentadecyl-9H-xanthene-9-one (0.18 g, 0.43 mmol), K2S2O8 (0.46 g, 1.70 mmol), [Ru(p-isopropyltoluene)Cl2]2 (13.1 mg, 0.022 mmol), TFAA (5.0 mL) and TFA (2.0 mL). Seal the reaction with a polytetrafluoroethylene-lined lid and heat at 80°C and monitor with TLC. After completion, add EtOAc to dilute the reaction mixture, and add saturated NaHCO3 aqueous solution to neutralize TFA and TFAA. Then use anhydrous Na2SO4 to dry the organic layer and concentrate in vacuo. Finally, the residue was purified by silica gel column chromatography (5% EtOAc / hexanes) to provide 1,8-dihydroxy-3-pentadecyl-9H-xanthene-9-one 14 (121 mg, 64%) as an off-white solid. Mp. 92.3-93.2°C; IR : 2915, 2849, 1633, 1595, 1490, 1471, 1316, 1233, 1079, 1055, 831, 747, 732; 1 H NMR (600MHz, chloroform-d) δ11.92(s,1H,C8-OH),11.75(s,1H,C1-OH),δ7.61(t,J=8.4 ,8.4Hz,1H,H6),6.91(dd,J=8.4,0.9Hz,1H,H5),6.80(dd,J=8.3,0.9Hz,1H,H7) ,6.77(d,J=1.4Hz,1H,H4),6.66(d,J=1.4Hz,1H,H2),2.69(t,2H,H1′),1.75–1 .64(m,2H,H2′),1.39–1.24(m,24H,H3′-H14′),0.89(t,J=5.9Hz,3H,H15′)ppm; 13C NMR (151 MHz, chloroform-d) δ 185.7 (C=O), 161.3 (C8), 161.0 (C1), 156.3 (C10a), 156.2 (C4a), 154.9 (C3), 137.2 (C6), 111.0 (C2), 110.7 (C7), 107.8 (C8a), 107.1 (C4), 107.1 (C5) ,106.0(C9a),36.8(C1′),31.9(C13′),30.6(C2′),29.7(5C),29.6(1C),29.5(1C),29.4(1C),29.2(1C),26.9(1C),22.7(C14′),14.2(C15′)ppm; HRMS(ESI+): found (M+H) + 439.2861, C 28 H 39 O4(M+H) + Requires 439.2843.
[0209] 2-Hydroxy-4-pentadecylbenzaldehyde 18
[0210] To a stirred mixture of 3-pentadecylphenol 7 (3.04 g, 9.85 mmol), tri-n-butylamine ((0.4 M) and tin tetrachloride (0.26 g, 0.115 mL, 0.96 mmol) in toluene (50 mL) was added paraformaldehyde (0.65 g, 21.67 mmol) at room temperature and after 30 min the yellow solution was heated at 100 °C for 8 h. The reaction mixture was then cooled and then poured into water acidified with 2 m HCl and extracted with ether. The ether extract was washed with brine, dried over Na2SO4 and concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (5% EtOAc / cyclohexane) to provide 2-hydroxy-4-pentadecylbenzaldehyde 18 (2.45 g, 77%) as a white solid. Mp. 50.6-51.8 °C; IR : 2914, 2848, 1667, 1626, 1470, 1306, 1191, 1128, 797, 735; 1 H NMR (400 MHz, chloroform-d) δ 11.06 (s, 1H, C2-OH), 9.85 (s, 1H, CHO), 7.46 (d, J = 7.8 Hz, 1H, H6), 6.85 (dd, J = 7.9, 1.5 Hz, 1H, H5), 6.82 (d, J = 1.4 Hz, 1H, H3), 2.63 (t, 2H, H1′), 1.76–1.48 (m, 2H, H2′), 1.40–1.18 (m, 24H, H3′-H14′), 0.89 (t, J = 5.7 Hz, 3H, H15′) ppm;13 C NMR (101 MHz, chloroform-d) δ 195.8 (CHO), 161.8 (C2-OH), 153.8 (C4), 133.6 (C6), 120.5 (C5), 118.8 (C1), 117.1 (C3), 36.4 (C1′), 31.9 (C13′), 30.7 (C2′), 29.7 (6C), 29.6 (1C), 29.5 (1C), 29.4 (1C), 29.3 (1C), 22.7 (C14′), 14.1 (C15′) ppm; HRMS (ESI+): found (M+H) + 333.2786, C 22 H 37 O2(M+H) + 333.2788 is required. This data is consistent with that reported in the literature.
[25]
[0211] 2-(Hydroxymethyl)-5-pentadecylphenol 19
[0212] In a 25mL round-bottom flask, under inert conditions, 2-hydroxy-4-pentadecylbenzaldehyde 18 (0.48g, 1.44mmol) was dissolved in 15mL freshly distilled dry THF. The reaction was cooled to 0°C and LiAlH was carefully added (0.22g, 5.78mmol). The reaction was slowly warmed to room temperature and stirred for 2h. After completion, the reaction was cooled to 0°C again and 2% NaOH aqueous solution (10mL) was added dropwise to quench unreacted LiAlH, then diluted with ice-cold water (25mL). Organic matter was extracted with EtOAc (3 × 320mL), and the organic phases combined were washed with brine (50mL), anhydrous Na was used SO was dried, filtered, and the solvent was removed in vacuo to obtain a crude product, which was then subjected to column chromatography (20% EtOAc / cyclohexane) to obtain 2- (hydroxymethyl) -5-pentadecylphenol 19 (0.39g, 81%) in a white crystalline solid. Mp.94.6-95.9℃;IR : 3442,3165,2915,2847,1624,1592,1463,1440,1284,1125,992,826,753; 1H NMR (400MHz, chloroform-d) δ7.13(s,1H,C2-OH),6.93(d,J=7.6Hz,1H,H6),6.73(d,J=1.6Hz,1H,H3),6.67(dd,J=7.6,1.6Hz,1H,H5),4.83(s, 2H,CH2OH),2.54(t,2H,H1′),2.13(br,s,1H,),1.68–1.49(m,2H,H2′),1.42-1.17(m,24H,H3′-H14′),0.87(t,J=5.6Hz,3H,H15′)ppm; 13 C NMR (101 MHz, chloroform-d) δ 156.0 (C2), 145.0 (C4), 127.6 (C6), 121.9 (C1), 120.2 (C5), 116.5 (C3), 64.6 (-CH2OH), 35.7 (C1′), 31.9 (C13′), 31.3 (C2)′, 29.7 (6C), 29.6 (1C), 29.5 (1C), 29.4 (1C), 29.3 (1C), 22.7 (C14′), 14.1 (C15′) ppm; HRMS (ESI+): found (M+Na) + 357.2770, C 22 H 38 NaO2(M+Na) + Requires 357.2764. This data is consistent with that reported in the literature.
[26]
[0213] 2-(4,6-diphenyl-1,3,5-triazine-2-yl)-5-pentadecylphenol 20
[0214] A mixture of 2-(hydroxymethyl)-5-pentadecylphenol 19 (0.19 g, 0.57 mmol), benzamidine hydrochloride (0.15 g, 0.97 mmol), Na2CO3 (0.10 g, 0.97 mmol) and Cu(OAc)2 (10 mol%) was stirred in toluene (3.5 mL) at 110 ° C for 24 h. The resulting mixture was cooled to room temperature and then extracted with EtOAc (3×10 mL) and subsequently washed with brine. The organic phases were combined and dried over anhydrous Na2SO4 and evaporated under reduced pressure. The crude product was purified by silica gel column chromatography (5% EtOAc / cyclohexane) to give 2-(4,6-diphenyl-1,3,5-triazine-2-yl)-5-pentadecylphenol 20 (0.16 g, 62%) as a white crystalline solid. Mp.117.6-119.4 ° C; IR : 2915,2849,1587,1509,1470,1394,1365,1352,1314,1232,753,689; 1 H NMR (400 MHz, CHLOROFORM-d) δ 13.27 (s, 1H, C1-OH), 8.66 (dd, J = 11.2, 7.8 Hz, 6H, H2″ and H4″), 7.77–7.49 (m, 5H, H3″ and H3), 6.93 (d, J = 1.6 Hz, 1H, H6)), 6.89 (dd, J = 8.2, 1.7 Hz, 1H, H4), 2.68 (t, 2H, H1″′), 1.77–1.66 (m, 2H, H2″′), 1.41–1.22 (m, 24H, H3″′-H14″′)(0.90 (t, J = 5.8, 3H, H15″′) ppm; 13 C NMR (101 MHz, chloroform-d) δ 171.9 (C2′ and C6′, 162.2 (C1), 151.5 (C5), 135.3 (C1″), 133.0 (C2″), 129.8 (C3), 129.0 (C3″), 128.8 (C4″), 120.1 (C4), 117.7 (C6), 115.2 (C2), 36.2 (C1″′), 31.9 (C13″′), 30.9 (C2″′), 29.7 (6C), 29.6 (1C), 29.5 (1C), 29.4 (1C), 29.3 (1C), 22.7 (C14″′), 14.1 (C15″′) ppm; HRMS (ESI+): found (M+H) + 536.3643, C 36 H 46 NO3(M+H) + Requires 536.3636.
[0215] 2-Hydroxy-4-pentadecylbenzonitrile 22
[0216] 2-Hydroxy-4-pentadecanylbenzaldehyde 18 (1.05 g, 3.15 mmol) and hydroxylamine hydrochloride (0.29 g, 4.10 mmol) were added to a 20 mL dry DMF solution of anhydrous ferric chloride (0.26 g, 1.58 mmol) in sequence. The mixture was refluxed for 16 h. After the reaction was complete, the solution was poured into 200 mL of water and extracted with EtOAc (3 × 50 mL), and washed with water several times. The combined organic mixture was dried over anhydrous Na2SO4, concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (20% EtOAc / cyclohexane) to supply 2-hydroxy-4-pentadecanylbenzonitrile 22 (0.82 g, 80%) as a white solid. Mp.71.4-72.9 ° C; IR : 3273,2957,2915,2851,2229,1615,1585,1470,1439,1310,949,874,796; 1 H NMR (400 MHz, chloroform-d) δ7.42 (d, J = 7.9 Hz, 1H, H6), 6.85 (d, J = 1.4 Hz, 1H, H3), 6.82 (dd, J = 7.9, 1.4 Hz, 1H, H5), 6.64 (s, 1H, C2-OH), 2.61 (t, 3H, H1′), 1.67–1.56 (m, 2H, H2′), 1.35–1.23 (m, 24H, H3′-H14′), 0.89 (t, J = 5.6 Hz, 3H, H15′) ppm; 13 C NMR (101 MHz, chloroform-d) δ 158.7 (C2), 151.3 (C4), 132.6 (C6), 121.4 (C5), 116.8 (C1′), 116.4 (C3), 96.5 (C1), 36.2 (C1″), 31.9 (C13″), 30.8 (C2″), 29.7 (6C), 29.6 (1C), 29.4 (1C), 29.4 (1C), 29.2 (1C), 22.7 (C14″), 14.1 (C15″) ppm; HRMS: found (M+Na) + 352.2605, C 22 H 35 NNaO(M+Na) + Requires 352.2611.
[0217] 6,6',6"-(1,3,5-triazine-2,4,6-triyl)tri(3-pentadecylphenol)21
[0218] 2-Hydroxy-4-pentadecylbenzonitrile 22 (0.37 g, 1.12 mmol) was placed in a microwave reactor tube. The tube was sealed and then subjected to microwave irradiation (200 W, 220 ° C) for 3 h. After cooling, the crude product was purified by column chromatography (5% EtOAc / cyclohexane) to give 6,6',6"-(1,3,5-triazine-2,4,6-triyl)tris(3-pentadecylphenol) 21 (0.133 g, 73%) as a light yellow crystalline solid. Mp. 75.8-77.7 ° C; IR : 2916, 2848, 1630, 1584, 1535, 1494, 1386, 1361, 1310, 1228, 1161, 799; 1H NMR (400 MHz, chloroform-d) δ 12.98 (s, 1H, C1-OH), 8.04 (d, J = 8.2 Hz, 1H, H5), 6.90 (s, 1H, H2), 6.85 (dd, J = 8.4, 1.5 Hz, 1H, H4), 2.64 (t, J = 7.7 Hz, 2H, H1″), 1.73–1.61 (m, 2H, H2″), 1.40–1.20 (m, 24H, H3″-H14″), 0.89 (t, J = 5.6 Hz, 3H, H15″); 13 C NMR (101 MHz, chloroform-d) δ 169.2 (C2′), 162.8 (C1), 152.9 (C3), 128.7 (C5), 120.7 (C4), 118.1 (C2), 113.4 (C6), 36.2 (C1″), 31.9 (C13″), 30.7 (C2″), 29.7 (6C), 29.6 (1C), 29.5 (1C), 29.4 (1C), 29.4 (1C), 22.7 (C14″), 14.1 (C15″); HRMS: found (M+H) + , C 66 H 106 N3O3(M+H) + Requires 988.8229.
[0219] 3,4-Dimethoxybenzoic acid hydrazide 24
[0220] Palladium on activated carbon (10 wt%, 645 mg, 0.61 mmol) was added to a stirred suspension of veratraldehyde (2.00 g, 12.0 mmol) and NaOH (1.07 g, 26.4 mmol) in water (48 mL) at room temperature. The mixture was stirred at 80 °C and 800 mbar under reduced pressure for 20 h. After cooling to room temperature, the mixture was stirred by Filter and pour into 1N H2SO4 (60mL). The resulting precipitate was collected by filtration and washed with water (120mL). The filtrate was extracted with EtOAc (3×20mL), and the combined organic extracts were dried over Na2SO4. After evaporation of the solvent, the resulting solid was combined with the filtration residue and dried under reduced pressure to obtain 3,4-dimethoxybenzoic acid (1.92 g, 10.5 mmol, 87%) as a colorless solid. Mp.178.3–180.1°C; IR : 2964,2836,1671,1516,1298,1266,1232,1023,917,758; 1H NMR (300MHz, chloroform-d) δ11.39(s,1H,CO2H),7.79(dd,J=8.4,2.0Hz,1H,H6),7.60(d,J=2.0 Hz,1H,H2),6.92(d,J=8.5Hz,1H,H5),3.96(s,3H,C4-OCH3),3.95(s,3H,C3-OCH3)ppm; 13 C NMR (76 MHz, chloroform-d) δ 172.0 (CO2H), 153.7 (C4) 148.7 (C3), 124.6 (C6), 121.7 (C1), 112.3 (C2), 110.3 (C5), 56.1 (C4-OCH3), 56.0 (C3-OCH3) ppm; MS (ESI+): m / z (%) = 181.1 (100) [M–H] – . The analytical data are consistent with the literature.
[27] A solution of 3,4-dimethoxybenzoic acid (800 mg, 4.39 mmol) and concentrated H2SO4 (90.0 μL, 1.62 mmol) in EtOAc (5 mL) was stirred under reflux for 18 h. After cooling to room temperature, the solvent was evaporated and the residue was dissolved in ether (15 mL). After washing with saturated NaHCO3 (5 mL) and drying with Na2SO4, the solvent was evaporated to obtain ethyl 3,4-dimethoxybenzoate (868 mg, 4.13 mmol, 94%) as a colorless oil. IR : 2979, 2839, 1708, 1514, 1345, 1290, 1269, 1177, 1025, 763; 1 H NMR (300MHz, chloroform-d) δ7.68(dd,J=8.4,2.0Hz,1H,H6),7.55(d,J=2.0Hz,1H,H2),6.88(d,J=8.4Hz,1H,H 5), 4.36 (q, J = 7.1Hz, 2H, CH2CH3), 3.93 (s, 6H, C3-OCH3, C4-OCH3), 1.39 (t, J = 7.1Hz, 3H, CH2CH3) ppm; 13 C NMR(76MHz, chloroform-d)δ166.4(CO2Et),152.8(C4)148.5(C3),123.4(C6),123.0(C1),111.9(C2),110.2(C5 ), 60.8 (CH2CH3), 56.0 (2C, C3-OCH3, C4-OCH3), 14.4 (CH2CH3)ppm; MS (ESI+): m / z (%) = 211.1 (100) [M+H] + ,233.1(5)[M+Na] +. The analytical data were consistent with the literature.
[28] A solution of ethyl 3,4-dimethoxybenzoate (868 mg, 4.13 mmol) and hydrazine hydrate (64 wt%, 600 μL, 12.4 mmol) in EtOH (0.3 mL) was refluxed with stirring for 18 h. After cooling to room temperature, the solvent was evaporated and the residue was dissolved in water (10 mL). The resulting solution was extracted with EtOAc (10×10 mL), and the combined organic extracts were dried over Na2SO4 and evaporated to obtain 3,4-dimethoxybenzohydrazide 24 (770 mg, 3.92 mmol, 95%) as a colorless solid. Mp.132.8–134.4°C; IR : 3307,2939,2845,1626,1500,1275,1148,1073,957,635; 1 H NMR(300MHz,DMSO-d6)δ9.62(s,1H,NHNH2),7.44(dd,J=8.2,1.2Hz,1H,H6),7.42(d,J=2.0H z,1H,H2),6.99(d,J=8.2Hz,1H,H5),4.42(s,2H,NHNH2),3.79(s,6H,C3-OCH3,C4-OCH3)ppm; 13 C NMR(76MHz,DMSO-d6)δ165.5(CO2NHNH2),151.0(C4)148.1(C3),125.4(C1),120.0(C6),110.8(C5),11 0.1 (C2), 55.5 (C3-OCH3 / C4-OCH3), 55.4 (C3-OCH3 / C4-OCH3)ppm; MS (ESI+): m / z (%) = 197.4 (100) [M+H] + ,219.3(22)[M+Na] + The analysis data are consistent with the literature.
[16]
[0221] 2-[5-(3,4-dimethoxyphenyl)-1,3,4-oxadiazol-2-yl]-5-pentadecylphenol 25
[0222] 3,4-dimethoxybenzohydrazide 24 (325 mg, 1.66 mmol) was added to a stirred solution of 2-hydroxy-4-pentadecanylbenzaldehyde (500 mg, 1.51 mmol) in ether (3.5 mL) and MeOH (3.5 mL). The resulting mixture was stirred at room temperature overnight. During this period, a colorless solid was precipitated, which was collected by filtration, washed with cyclohexane / EtOAc=10 / 1 (30 mL), and dried under reduced pressure. N'-[(2-hydroxy-4-pentadecanylphenyl)methylene]-3,4-dimethoxybenzohydrazide 25 (623 mg, 1.22 mmol, 82%) was thus obtained as a colorless solid. Mp.123.7–125°C; IR : 3225,2918,2849,1639,1415,1271,1194,1132,1022,771; 1 H NMR (600 MHz, acetone-d6) δ 11.64 (s, 1H, OH), 11.21 (s, 1H, NH), 8.51 (s, 1H, CHN), 7.61 (dd, J = 8.3, 2.0 Hz, 1H, H6), 7.57 (d, J = 2.0 Hz, 1H, H2), 7.23 (d, J = 7.7 Hz, 1H, H6'), 7.06 (d, J = 8.4 Hz, 1H, H5), 6.79 (s,1H,H3'),6.77(d,J=7.7Hz,1H,H5'),3.88(s,6H,C3-OCH3,C4-OCH3),2.59(t,J=7.8Hz,2H,H1 "),1.62(q,J=7.8Hz,2H,H2''),1.34–1.23(m,24H,H3"–H14''),0.87(t,J=6.9Hz,3H,H15")ppm; 13 C NMR (151 MHz, acetone-d6) δ 162.2 (CONH), 158.6 (C2'), 152.6 (C4), 149.2 (C3), 149.1 (CHN), 146.9 (C4'), 130.7 (C6'), 125.2 (C1), 120.7 (C6), 119.5 (C5'), 116.5 (C3'), 115.9 (C1'), 110.9 ( C5),110.8(C2),55.2(2C,C3-OCH3,C4-OCH3),35.6(C1″),31.8(C13″),31.0(C2″),29.5(6 C),29.4,29.3,29.2(2C),22.5(C14″),13.5(C15″)ppm; MS(ESI+): m / z(%)511.7(100)[M+H] +; HRMS (ESI+): found (M+H) + 511.3514, C 31 H 47 N2O4(M+H) + Requires 511.3536.
[0223] 2-[5-(3,4-dimethoxyphenyl)-1,3,4-oxadiazol-2-yl]-5-pentadecylphenol 23
[0224] To a stirred solution of N'-[(2-hydroxy-4-pentadecylphenyl)methylene]-3,4-dimethoxybenzohydrazide 25 (100 mg, 196 μmol) in dry acetone (4 mL) was added PIDA (126 mg, 392 μmol) under argon atmosphere. The resulting mixture was stirred at room temperature for 2.5 h, and another portion of PIDA (63.1 mg, 196 μmol) was added. After stirring for an additional 2.5 h, the solvent was evaporated, and the residue was purified by silica gel column chromatography (5-70% EtOAc / cyclohexane) to obtain 2-[5-(3,4-dimethoxyphenyl)-1,3,4-oxadiazol-2-yl]-5-pentadecylphenol 23 (46.3 mg, 91.0 μmol, 47%) as a light yellow solid. Mp. 106.5–107.9 °C; IR : 2955, 2919, 2850, 1609, 1583, 1503, 1469, 1284, 1229, 1098, 721; 1 H NMR (400 MHz, chloroform-d) δ 10.12 (s, 1H, OH), 7.75 (d, J = 8.0 Hz, 1H, H3), 7.71 (dd, J = 8.4, 2.0 Hz, 1H, H6'), 7.64 (d, J = 2.0 Hz, 1H, H2'), 7.00 (d, J = 8.4 Hz, 1H, H5'), 6.97 (d, J = 1.4 Hz, 1H, H6), 6.86 (dd, J=8.0,1.6Hz,1H,H4),4.01(s,3H,C3'-OCH3),3.98(s,3H,C4'-OCH3),2.64(t,J=7.5Hz,2H,H1 “),1.63(q,J=7.3Hz,2H,H2“),1.33–1.23(m,24H,H3“–H14''),0.88(t,J=6.8Hz,3H,H15“)ppm; 13C NMR (101 MHz, chloroform-d) δ 164.0 (oxadiazole-C2), 163.0 (oxadiazole-C5), 157.6 (C1), 152.3 (C4'), 149.7 (C5), 149.4 (C3'), 128.6 (C6'), 126.2 (C3), 120.4 (C4), 117.2 (C6), 115.9 (C1'), 111.1 (C5'), 109.4 (C2 '),105.8(C2),56.2(C3'-OCH3),56.1(C4'-OCH3),36.1(C1″),31.9(C13″),30.9(C2″),29.7( 6C),29.6,29.5,29.4,29.2,22.7(C14″),14.1(C15″)ppm; MS(ESI+): m / z(%)=509.6(100)[M+H] + ; HRMS (ESI+): found (M+H) + 509.3372, C 31 H 45 N2O4(M+H) + Requires 509.3379.
[0225] References
[0226] 1 (a) HCJames and IDFabien, Introduction to Chemical from biomass, 2008, John Wiley and Sons, United Kingdom; (b) A.Behr, L.Johnen, Alternative Feedstocks for Synthesis, Ch-J.Li Handbook of Green Chemistry, Volume 7: GreenSynthesis, first ed., Wiley-VCH, Weinheim, 2012, 69–92.
[0227] 2 (a)EMSerum,S.Selvakumar,N.Zimmermannnc,MPSibi,Green Chem.,2018,20,1448-1454;(b)J.Sze Ki Lin,LAPfaltzgraff,L.Herrero-Davila,EBMubofu,S.Abderrahim,JHClark,AAKoutinas,N.Kopsahelis,K.Stamatelatou,F.Dickson,S.Thankappan,Z.Mohamed,R.Brocklesby and R.Luque,Energy Environ.Sci.
[0228] 3 AMMurtala,NNShawal and HDUsman,Int.J.Eng.Sc.and Tech.,2012,4,721-730.
[0229] 4 (a)Y.Xu,MAHanna and L.Isom,The Open Agric.J.,2008,2,54-61;(b)PLRivilli,GIYranzo and JDPerez,Bio.Resources,2011,6,2703-2710;(c)F.Jinand H.Enomoto,Bio.Resources,2009,4,704-713.
[0230] 5 Cosmetics:(a)V V.Costa,KAda Silva Rocha,LCAOliveira,EFKozhevnikova,IVKozhevnikovc and E V.Gusevskaya,RSC Adv.,2016,6,43217-43222;(b)FGDelolo,KCBOlive,andira Molescular Gudoskaya,EV Catalysis 2019,462 1–9;(c) ALPdeMeireles , M dosSantos Costa , K.A. Silva Rocha , EFKozhevnikova , IVKozhevnikov and EVGusevskayaChemCatChem,2014,6,2706-2711.Chemicals andpharmaceuticals:(a)A.Corma,S.Iborraand A.Velty,Chem.Rev.2007,107,2411;(b)T.A.Bender,J.A.Dabrowski and M.R.Gagne,Nature Reviews Chemistry 2018,35–46;(c)S.Baader,P.E.Podsiadly,D.J.Cole-Hamilton and L.J.Goossen,Green Chemistry,2014,16,4885-4890.
[0231] 6 (a)See for example(i)D.Stubba,G.Lahm,M.Geffe,J.W.Runyon,A.J.Arduengo III and Till Opatz,Angew.Chem.Int.Ed.2015,54,14187–14189;(ii)J.Kühlborn,A.-K.Danner,H.Frey,R.Iyer,A.J.Arduengo,III and Till Opatz,GreenChem.,2017,19,3780–3786;(b)See for example(i)J.A.Mmongoyo,Q.A.Mgani,S.J.M.Mdachi,P.J.Pogorzelec and D.J.Cole-Hamilton,Eur.J.Lipid Sci.Technol.2012,114,1183–1192;(ii)C.Voirin,S.Caillol,N.V.Sadavarte,B.V.Tawade,B.Boutevin andP.P.Wadgaonk,Polym.Chem.2014,5,3142-3162;(iii)S.Caillol,Current Opinion inGreen and Sustainable Chemistry 2018,14:26–32;(iv)M.Hemshekhar,M.S.Santhosh,K.Kemparaju and K.S.Girish,Basic&Clinical Pharmacology&Toxicology,2011,110,122–132;(v)V.S.BalachandranS.R.Jadhav,P.Kumar Vemula and G.John,Chem.Soc.Rev.,2013,42,427-427.
[0232] 7 I.Kubo,H.Muroi and M.Himejima,J.Agric.Food Chem.,1993,41,1016–1019;M.S.C.Oliveira,S.M.Morais,D.V. Acta.Trop.2010,117,165–170;Y.Wu,L.He,L.Zhang,J.Chen,Z.Yi,J.Zhang,M.Liu and X.Pang,J.Pharmacol.Exp.Ther.,2011,339,403–411.
[0233] 8 PGParejo, M. Zayata and D. Levy, J. Mater.Chem., 2006, 16, 2165–2169.
[0234] 9 (a)DLGiokas,A.Salvador and A.Chisvert,Trends Anal Chem.,2007,26,360–374;(b)BAMCSantosa,ACPda Silva,MLBello,AS Journal of Photochemistry and Photobiology A:Chemistry, 2018, 356, 219-229.
[0235] 10 M.Zayat,PGPair and D.Levy,Chem.Soc.Rev.,2007,36,1270–1281.
[0236] 11 A.Maliakal,G.Lem,NJTurro,R.Ravichandran,JCSuhadolnik,ADDeBellis,MGWood and J.Lau,J.Phys.Chem.A,2002,106,7680–7689;PFMcGarry,S.Jockusch,Y.Fujiwara,NAKaprindis and NJTurro, J. Phys.Chem.A, 1997, 101, 764–767.
[0237] 12 (a)Sunscreens:K.Morabito,N.C.Shapley,K.G.Steeley and A.Tripathi,International Journal of Cosmetic Science,2011,33,385–390;(b)Steinberg,D.C.(2005)Regulations of sunscreens worldwide.In Sunscreens(Edited byN.A.Shaath),pp.173–198.Taylor&Francis,Boca Raton,FL.
[0238] 13 P.Gago-Ferrero,M.S.Díaz-Cruz and D.Barceló,Anal.Bioanal.Chem.,2012,404:2597–2610.
[0239] 14 (a)M.Mosquera,J.C.Penedo,M.C.R. and F. J.Phys.Chem.,1996,100,5398–5407;(b)G.Woessner,G.Goeller,P.Kollat,J.J.Stezowski,M.Hauser,U.K.A.Klein and H.E.A.Kramer,J.Phys.Chem.,1984,88,5544–5550;(d)W. Adv.Photochem.,1977,10,311–358.
[0240] 15 K.G.Rutherford,W.Redmond and C.S,B.Rigamonti,C.S.B.,J.Org.Chem,196126,5149-5152.
[0241] 16 B.Narasimhan,S.Ohlan,R.Ohlan,V.Judge and R.Narang,Eur.J.Med.Chem.2009,44,689-700.
[0242] 17 H.M.Chawla,N.Pant,S.Kumar,S.Mrig,B.Srivastava,N.Kumar andD.StC.Black,J.Photochemistry and Photobiology B:Biology,2011,105,25–33.
[0243] 18 R.A.Sheldon,Current Opinion in Green and Sustainable Chemistry2019,18,13–19.
[0244] 19 R.A.Sheldon and J.M.Woodley,Chem.Rev.2018,118,801-838
[0245] 20 N.S.Reddy,A.S.Rao,M.A.Chari,V.R.Kumar,V.Jyothy,V.Himabindu,Lett.Org.Chem.2012,9,287-293.
[0246] 21 R.Zehnter,H.Gerlach,Liebigs Annalen 1995,1995,2209-2220.
[0247] 22 D.L.J.Clive,A.Khodabocus,P.G.Vernon,A.G.Angoh,L.Bordeleau,D.S.Middleton,C.Lowe,D.Kellner,J.Chem.Soc.,Perkin Trans.1 1991,1433-1444.
[0248] 23 K.K.Julich-Gruner,O.Kataeva,A.W.Schmidt,H.-J. Chem.Eur.J.2014,20,8536-8540.
[0249] 24 R.Bernini,S.Cacchi,I.De Salve,G.Fabrizi,Synthesis,2007,6,873-882.
[0250] 25 P.Payne,J.H.P.Tyman,S.K.Mehet and A Ninagawa,J.Chem.Res.2006,402-405.
[0251] 26 J.H.P.Tyman and S.K.Mehet,Chem.and Phys.of Lipids,2003,126,177-199.
[0252] 27 G.W.Perold,L.Carlton,A.S.Howard,J.P.Michael,J.Chem.Soc.,PerkinTrans.1 1988,881-884.
[0253] 28 B.Teng,J.Shi,C.Yao,Green Chem.2018,20,2465-2471.
Claims
1. A compound having excited state intramolecular proton transfer (ESIPT) properties, the compound being at least one selected from the group consisting of: (i). (ii). (iii). (iv). (v). (vi). and (vii). wherein for compounds (i) to (vii), R and / or R1 and / or R2 may each be at least one substituent or moiety located at one or more of the ortho, meta and / or para positions on the benzene ring, and may be selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, cycloalkynyl, aryl, heteroaryl, heteroalicyclic, aralkyl, heteroaralkyl, (heteroalicyclic)alkyl, hydroxyl, protected hydroxyl, alkoxy, aryloxy, acyl, thiol, thioalkyl, arylthio, cyano, halogen, Thiocarbonyl, O-carbamoyl, N-carbamoyl, O-thiocarbamoyl, N-thiocarbamoyl, C-amide, N-amide, S-sulfonamide, N-sulfonamide, C-carboxyl, protected C-carboxyl, O-carboxyl, isocyanato, thiocyanato, isothiocyanato, nitro, nitrile, silyl, thiocyano, sulfinyl, sulfonyl, haloalkyl, haloalkoxy, trihalomethanesulfonyl, trihalomethanesulfonamido, amino, monosubstituted amino, disubstituted amino, ester, alcohol, acetate.
2. Any one or more of compounds (i) to (vii) for use in treating and / or preventing sunburn on the human or animal body, wherein compounds (i) to (vii) are: (i). (ii). (iii). (iv). (v). (vi). and (vii). wherein for compounds (i) to (vii), R and / or R1 and / or R2 may each be at least one substituent or moiety located at one or more of the ortho, meta and / or para positions on the benzene ring, and may be selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, cycloalkynyl, aryl, heteroaryl, heteroalicyclic, aralkyl, heteroaralkyl, (heteroalicyclic)alkyl, hydroxyl, protected hydroxyl, alkoxy, aryloxy, acyl, thiol, thioalkyl, arylthio, cyano, halogen, Thiocarbonyl, O-carbamoyl, N-carbamoyl, O-thiocarbamoyl, N-thiocarbamoyl, C-amide, N-amide, S-sulfonamide, N-sulfonamide, C-carboxyl, protected C-carboxyl, O-carboxyl, isocyanato, thiocyanato, isothiocyanato, nitro, nitrile, silyl, thiocyano, sulfinyl, sulfonyl, haloalkyl, haloalkoxy, trihalomethanesulfonyl, trihalomethanesulfonamido, amino, monosubstituted amino, disubstituted amino, ester, alcohol, acetate.
3. A composition formulated by any one or more of the compounds (i)-(vii) for treating and / or preventing sunburn on the human or animal body, wherein the composition comprises at least one selected from the group consisting of: water, glycerin, trisodium ethylenediaminetetraacetic acid (EDTA), tocopheryl acetate, phenoxyethanol, cetyl alcohol, xanthan gum, polyethylene glycol (PEG), sodium cetearyl sulfate, glyceryl stearate and fragrance, Wherein compounds (i)-(vii) are: (i). (ii). (iii). (iv). (v). (vi). and (vii). wherein for compounds (i) to (vii), R and / or R1 and / or R2 may each be at least one substituent or moiety located at one or more of the ortho, meta and / or para positions on the benzene ring, and may be selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, cycloalkynyl, aryl, heteroaryl, heteroalicyclic, aralkyl, heteroaralkyl, (heteroalicyclic)alkyl, hydroxyl, protected hydroxyl, alkoxy, aryloxy, acyl, thiol, thioalkyl, arylthio, cyano, halogen, Thiocarbonyl, O-carbamoyl, N-carbamoyl, O-thiocarbamoyl, N-thiocarbamoyl, C-amide, N-amide, S-sulfonamide, N-sulfonamide, C-carboxyl, protected C-carboxyl, O-carboxyl, isocyanato, thiocyanato, isothiocyanato, nitro, nitrile, silyl, thiocyano, sulfinyl, sulfonyl, haloalkyl, haloalkoxy, trihalomethanesulfonyl, trihalomethanesulfonamido, amino, monosubstituted amino, disubstituted amino, ester, alcohol, acetate.
4. Use of a compound having excited state intramolecular proton transfer (ESIPT) properties in the preparation of a composition for treating and / or preventing sunburn of a human or animal body, the compound being produced from cashew nut shell liquid (CNSL), wherein the compound is at least one selected from the group consisting of: (i). (ii). (iii). (iv). (v). (vi). and (vii). wherein for compounds (i) to (vii), R and / or R1 and / or R2 may each be at least one substituent or moiety located at one or more of the ortho, meta and / or para positions on the benzene ring, and may be selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, cycloalkynyl, aryl, heteroaryl, heteroalicyclic, aralkyl, heteroaralkyl, (heteroalicyclic)alkyl, hydroxyl, protected hydroxyl, alkoxy, aryloxy, acyl, thiol, thioalkyl, arylthio, cyano, halogen, Thiocarbonyl, O-carbamoyl, N-carbamoyl, O-thiocarbamoyl, N-thiocarbamoyl, C-amide, N-amide, S-sulfonamide, N-sulfonamide, C-carboxyl, protected C-carboxyl, O-carboxyl, isocyanato, thiocyanato, isothiocyanato, nitro, nitrile, silyl, thiocyano, sulfinyl, sulfonyl, haloalkyl, haloalkoxy, trihalomethanesulfonyl, trihalomethanesulfonamido, amino, monosubstituted amino, disubstituted amino, ester, alcohol, acetate.
5. The use according to claim 4, wherein the compound is formulated into the composition, and wherein the composition comprises at least one selected from the group consisting of: water, glycerin, trisodium ethylenediaminetetraacetic acid (EDTA), tocopheryl acetate, phenoxyethanol, cetyl alcohol, xanthan gum, polyethylene glycol (PEG), sodium cetearyl sulfate, glyceryl stearate and fragrance.
6. A method for producing a compound having excited state intramolecular proton transfer (ESIPT) properties, the method comprising the following steps: (a) Separation of phenolic compounds from cashew nut shell liquid (CNSL); (b) converting the separated phenolic compound into the compound having excited state intramolecular proton transfer (ESIPT) properties, wherein step (b) comprises converting the separated phenolic compound into at least one compound selected from the group consisting of: (i). (ii). (iii). (iv). (v). (vi). and (vii). wherein for compounds (i) to (vii), R and / or R1 and / or R2 may each be at least one substituent or moiety located at one or more of the ortho, meta and / or para positions on the benzene ring, and may be selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, cycloalkynyl, aryl, heteroaryl, heteroalicyclic, aralkyl, heteroaralkyl, (heteroalicyclic)alkyl, hydroxyl, protected hydroxyl, alkoxy, aryloxy, acyl, thiol, thioalkyl, arylthio, cyano, halogen, Thiocarbonyl, O-carbamoyl, N-carbamoyl, O-thiocarbamoyl, N-thiocarbamoyl, C-amide, N-amide, S-sulfonamide, N-sulfonamide, C-carboxyl, protected C-carboxyl, O-carboxyl, isocyanato, thiocyanato, isothiocyanato, nitro, nitrile, silyl, thiocyano, sulfinyl, sulfonyl, haloalkyl, haloalkoxy, trihalomethanesulfonyl, trihalomethanesulfonamido, amino, monosubstituted amino, disubstituted amino, ester, alcohol, acetate. 7 . The method according to claim 6 , wherein the phenolic compound comprises at least one of the group consisting of anacardic acid, cardanol, and cardanol.
8. A method for producing a compound having excited state intramolecular proton transfer (ESIPT) properties, the method comprising the following steps: (a) Separation of phenolic compounds from cashew nut shell liquid (CNSL); (b) converting the separated phenolic compound into the compound having excited state intramolecular proton transfer (ESIPT) properties, wherein step (b) comprises converting the separated phenolic compound into at least one compound selected from the group consisting of: (i). (ii). (iii). (iv). (v). (vi). and (vii). wherein for compounds (i) to (vii), R and / or R1 and / or R2 may each be at least one substituent or moiety located at one or more of the ortho, meta and / or para positions on the benzene ring, and may be selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, cycloalkynyl, aryl, heteroaryl, heteroalicyclic, aralkyl, heteroaralkyl, (heteroalicyclic)alkyl, hydroxyl, protected hydroxyl, alkoxy, aryloxy, acyl, thiol, thioalkyl, arylthio, cyano, halogen, Thiocarbonyl, O-carbamoyl, N-carbamoyl, O-thiocarbamoyl, N-thiocarbamoyl, C-amide, N-amide, S-sulfonamide, N-sulfonamide, C-carboxyl, protected C-carboxyl, O-carboxyl, isocyanato, thiocyanato, isothiocyanato, nitro, nitrile, silyl, thiocyano, sulfinyl, sulfonyl, haloalkyl, haloalkoxy, trihalomethanesulfonyl, trihalomethanesulfonamido, amino, monosubstituted amino, disubstituted amino, ester, alcohol, acetate. 9 . The method according to claim 8 , wherein the phenolic compound comprises at least one of the group consisting of anacardic acid, cardanol, and cardanol.
10. A compound having excited state intramolecular proton transfer (ESIPT) properties, said compound being produced according to the method according to any one of claims 6 to 9.
11. Use of a composition in the preparation of an ultraviolet absorber and a protective agent, the composition comprising a compound having excited state intramolecular proton transfer (ESIPT) properties produced from cashew nut shell liquid (CNSL), wherein the composition comprises at least one compound selected from the group consisting of: (i). (ii). (iii). (iv). (v). (vi). and (vii). wherein for compounds (i) to (vii), R and / or R1 and / or R2 may each be at least one substituent or moiety located at one or more of the ortho, meta and / or para positions on the benzene ring, and may be selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, cycloalkynyl, aryl, heteroaryl, heteroalicyclic, aralkyl, heteroaralkyl, (heteroalicyclic)alkyl, hydroxyl, protected hydroxyl, alkoxy, aryloxy, acyl, thiol, thioalkyl, arylthio, cyano, halogen, Thiocarbonyl, O-carbamoyl, N-carbamoyl, O-thiocarbamoyl, N-thiocarbamoyl, C-amide, N-amide, S-sulfonamide, N-sulfonamide, C-carboxyl, protected C-carboxyl, O-carboxyl, isocyanato, thiocyanato, isothiocyanato, nitro, nitrile, silyl, thiocyano, sulfinyl, sulfonyl, haloalkyl, haloalkoxy, trihalomethanesulfonyl, trihalomethanesulfonamido, amino, monosubstituted amino and disubstituted amino, ester, alcohol, acetate.
12. Use of a composition in the preparation of an ultraviolet absorber and a protective agent, the composition comprising a compound having excited state intramolecular proton transfer (ESIPT) properties produced from cashew nut shell liquid (CNSL), wherein the composition comprises at least one compound selected from the group consisting of: (i). (ii). (iii). (iv). (v). (vi). and (vii). wherein for compounds (i) to (vii), R and / or R1 and / or R2 may each be at least one substituent or moiety located at one or more of the ortho, meta and / or para positions on the benzene ring, and may be selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, cycloalkynyl, aryl, heteroaryl, heteroalicyclic, aralkyl, heteroaralkyl, (heteroalicyclic)alkyl, hydroxyl, protected hydroxyl, alkoxy, aryloxy, acyl, thiol, thioalkyl, arylthio, cyano, halogen, Thiocarbonyl, O-carbamoyl, N-carbamoyl, O-thiocarbamoyl, N-thiocarbamoyl, C-amide, N-amide, S-sulfonamide, N-sulfonamide, C-carboxyl, protected C-carboxyl, O-carboxyl, isocyanato, thiocyanato, isothiocyanato, nitro, nitrile, silyl, thiocyano, sulfinyl, sulfonyl, haloalkyl, haloalkoxy, trihalomethanesulfonyl, trihalomethanesulfonamido, amino, monosubstituted amino and disubstituted amino, ester, alcohol, acetate.
